Are you over 18 and want to see adult content?
More Annotations
ΤΑΜΕΙΑΚΕΣ ΜΗΧΑΝΕΣ ALPHAGRAM - ΑΣΥΝΑΓΩΝΙΣΤΕΣ ΤΙΜΕΣ
Are you over 18 and want to see adult content?
Strona główna - Eksperymentuj! - Zabawki naukowe, zabawki edukacyjne, zabawki fizyczne
Are you over 18 and want to see adult content?
Loveland Ski Area | Colorado Ski & Snowboard Resort
Are you over 18 and want to see adult content?
Красивые, качественные текстуры и фоны для дизайна, backgrounds
Are you over 18 and want to see adult content?
Crownit | India’s Most Trusted Market Research Platform
Are you over 18 and want to see adult content?
pbandt.bank | Local People Making Local Decisions
Are you over 18 and want to see adult content?
Favourite Annotations
Ethiopian Orthodox Tewahedo Church Sunday School Department Official Website
Are you over 18 and want to see adult content?
A complete backup of synn-solis.blogspot.com
Are you over 18 and want to see adult content?
Objective Questions (Engineering)
Are you over 18 and want to see adult content?
Tin Tây Nguyên, tin tức mới nhất về Tây Nguyên
Are you over 18 and want to see adult content?
Text
LIONEL Z. GLANCY
LIONEL Z. GLANCY, a graduate of University of Michigan Law School, is the founding partner of the Firm. After serving as a law clerk for United States District Judge Howard McKibben, he began his career as an associate at a New York law firm concentrating in securities litigation. Thereafter, he started a boutique law firm specializing in securities litigation, and other complex litigationATERIAN, INC.
Aterian, Inc. On May 4, 2021, Culper Research published a report titled “Aterian (ATER): Bought from Felons & Fraudsters, Sold to You,” alleging that Aterian has “ties to convicted criminals” and is “promoting what we believe is an overhyped ‘AI’ narrative and a string of garbage acquisitions to mask the failure of itsalready ill
TRUTH-IN-LENDING ACT VIOLATIONS Truth-In-Lending Act Violations. The Truth in Lending Act (“TILA”) is a federal statute that protects consumers from confusing or deceitful lending practices. As a consumer, you have the right to detailed and clear disclosures from your lender, including: Amount ofLIFEMD, INC.
Specifically, according to Culper Research, “many customers are effectively duped into purchasing subscriptions rather than one-time purchases” and LifeMD “makes cancellations difficult if not impossible.”. On this news, the Company’s share price fell $2.84, or 24%, to close at $9.00 per share on April 14, 2021, on unusuallyheavy
MARK S. GREENSTONE
MARK S. GREENSTONE specializes in consumer, financial fraud and employment-related class actions. Possessing significant law and motion and trial experience, Mr. Greenstone has represented clients in multi-million dollar disputes in California state and federal courts, as well as the Court of Federal Claims in Washington, D.C. Mr. Greenstone received his training as an associate at SheppardSKILLZ INC.
On this news, Skillz stock price fell $3.00 per share, or 10.9%, to close at $24.45, thereby injuring investors. On April 19, 2021, Eagle Eye Research posted an anonymous report on Twitter in which it claimed that, through the use of providing users with incentive Bonus Payments, “the company likely recognizes substantial non-cashrevenue and
GREGORY B. LINKH
GREGORY B. LINKH works out of the New York office, where he specializes in securities, shareholder derivative, antitrust, and consumer litigation. Greg graduated from the State University of New York at Binghamton in 1996 and from the University of Michigan Law School in 1999. While in law school, Greg externed with United States District Judge Gerald E. Rosen of the Eastern District ofPAVITHRA RAJESH
PAVITHRA RAJESH is a litigation associate in the firm’s Los Angeles office. She specializes in fact discovery, including pre-litigation investigation, and develops legal theories in securities, derivative, and privacy-related matters. Ms. Rajesh has unique writing experience from her judicial externship for the Patent Pilot Program in the United States District Court for the Central District NATIONAL CLASS ACTION LAWYERS With more than 25 years of experience litigating and winning cases on behalf of individuals, institutional investors, businesses, consumers, and employees, Glancy Prongay & Murray LLP (“GPM”) is recognized as one of the leading plaintiff’s law firms in the nation. Our team of highly qualified class action lawyers and research analysts OUR TEAM | GLANCY PRONGAY & MURRAY LLP Attorney & Staff Search. Search By Name Search By letter. A B C D E F G H I J K L M N O P Q R S T U V W X Y ZLIONEL Z. GLANCY
LIONEL Z. GLANCY, a graduate of University of Michigan Law School, is the founding partner of the Firm. After serving as a law clerk for United States District Judge Howard McKibben, he began his career as an associate at a New York law firm concentrating in securities litigation. Thereafter, he started a boutique law firm specializing in securities litigation, and other complex litigationATERIAN, INC.
Aterian, Inc. On May 4, 2021, Culper Research published a report titled “Aterian (ATER): Bought from Felons & Fraudsters, Sold to You,” alleging that Aterian has “ties to convicted criminals” and is “promoting what we believe is an overhyped ‘AI’ narrative and a string of garbage acquisitions to mask the failure of itsalready ill
TRUTH-IN-LENDING ACT VIOLATIONS Truth-In-Lending Act Violations. The Truth in Lending Act (“TILA”) is a federal statute that protects consumers from confusing or deceitful lending practices. As a consumer, you have the right to detailed and clear disclosures from your lender, including: Amount ofLIFEMD, INC.
Specifically, according to Culper Research, “many customers are effectively duped into purchasing subscriptions rather than one-time purchases” and LifeMD “makes cancellations difficult if not impossible.”. On this news, the Company’s share price fell $2.84, or 24%, to close at $9.00 per share on April 14, 2021, on unusuallyheavy
MARK S. GREENSTONE
MARK S. GREENSTONE specializes in consumer, financial fraud and employment-related class actions. Possessing significant law and motion and trial experience, Mr. Greenstone has represented clients in multi-million dollar disputes in California state and federal courts, as well as the Court of Federal Claims in Washington, D.C. Mr. Greenstone received his training as an associate at SheppardSKILLZ INC.
On this news, Skillz stock price fell $3.00 per share, or 10.9%, to close at $24.45, thereby injuring investors. On April 19, 2021, Eagle Eye Research posted an anonymous report on Twitter in which it claimed that, through the use of providing users with incentive Bonus Payments, “the company likely recognizes substantial non-cashrevenue and
GREGORY B. LINKH
GREGORY B. LINKH works out of the New York office, where he specializes in securities, shareholder derivative, antitrust, and consumer litigation. Greg graduated from the State University of New York at Binghamton in 1996 and from the University of Michigan Law School in 1999. While in law school, Greg externed with United States District Judge Gerald E. Rosen of the Eastern District ofPAVITHRA RAJESH
PAVITHRA RAJESH is a litigation associate in the firm’s Los Angeles office. She specializes in fact discovery, including pre-litigation investigation, and develops legal theories in securities, derivative, and privacy-related matters. Ms. Rajesh has unique writing experience from her judicial externship for the Patent Pilot Program in the United States District Court for the Central District CONTACT US | GLANCY PRONGAY & MURRAY LLP Our Locations. Glancy Prongay & Murray LLP Los Angeles. 1925 Century Park East Suite 2100 Los Angeles, CA 90067. 310-201-9150 Phone 310-432-1495 Fax. info@glancylaw.com CONTACT A TRADEMARK LITIGATION LAWYER FOR TRADEMARK Contact a Trademark Litigation Lawyer for Assistance. Trademark law helps businesses and institutions safeguard certain elements of their brand that make it unique. At Glancy Prongay & Murray, our trademark practice is built on decades of experience helping clients register their trademarks and protect them from infringement. ACELRX PHARMACEUTICALS, INC. AcelRx is a pharmaceutical company that develops therapies for the treatment of acute pain. One of its lead product candidates is DSUVIA, which has been approved by the U.S. FoodSKILLZ INC.
On this news, Skillz stock price fell $3.00 per share, or 10.9%, to close at $24.45, thereby injuring investors. On April 19, 2021, Eagle Eye Research posted an anonymous report on Twitter in which it claimed that, through the use of providing users with incentive Bonus Payments, “the company likely recognizes substantial non-cashrevenue and
OSCAR HEALTH, INC.
Oscar provides health insurance products and services to individuals, families, and businesses in the United States. The company was formerly known as Mulberry Health Inc. and chaSOS LIMITED
SOS Limited. On February 26, 2021, Hindenburg Research (“Hindenburg”) and Culper Research published reports regarding SOS, alleging that the Company was a "pump and dump" scheme that used fake addresses and doctored photos of crypto miners to create an illusion of success. The reports pointed out that SOS lists a hotelroom as the company
FREQUENCY THERAPEUTICS, INC. Frequency is a pharmaceutical company developing a hearing loss treatment titled “FX-322,” which the Company has long promoted as a potential treatment for patients with sever NEW YORK FIFTH AVENUE New York Securities Litigation Attorney Fifth Avenue 712 5th Avenue 31st Floor New York, NY 10019 Phone: 212-935-7400 toll-free: 877-935-7400 info@glancylaw.com New York Law Offices The attorneys at Glancy Prongay & Murray LLP have years of experience handling major litigation, including securities, antitrust, intellectual property, derivative, consumer products and employment cases MISAPPROPRIATION OF CORPORATE FUNDS Moreover, when a company’s executives misappropriated corporate funds, management’s positive statements regarding the company’s or its management’s honesty or integrity may be false. Such statements may too give rise to a securities fraud claim. Another possible action to take against insiders that misappropriated funds is the HOW A SECURITIES FRAUD TIP LED TO THE COLLEGE ADMISSIONS Read on to find out how a securities fraud tip got the ball rolling in the closely-watched college admissions cheating case. NATIONAL CLASS ACTION LAWYERS Glancy's class action lawyers litigate complex class action suits and individual claims against the world’s largest corporations in federal and state court. OUR TEAM | GLANCY PRONGAY & MURRAY LLP Attorney & Staff Search. Search By Name Search By letter. A B C D E F G H I J K L M N O P Q R S T U V W X Y ZSKILLZ INC.
On March 8, 2021, Wolfpack Research published a report about the Company alleging that the growth speculations from Skillz and its insiders were “entirely unrealistic” and thaATERIAN, INC.
On May 4, 2021, Culper Research published a report titled “Aterian (ATER): Bought from Felons & Fraudsters, Sold to You,” alleging that Aterian has “ties to convicted criminLIONEL Z. GLANCY
LIONEL Z. GLANCY, a graduate of University of Michigan Law School, is the founding partner of the Firm. After serving as a law clerk for United States District Judge Howard McKibben, he began his career as an associate at a New York law firm concentrating in securities litigation. Thereafter, he started a boutique law firm specializing in securities litigation, and other complex litigation CONTACT A TRADEMARK LITIGATION LAWYER FOR TRADEMARKSEE MORE ONGLANCYLAW.COM
MARK S. GREENSTONE
MARK S. GREENSTONE specializes in consumer, financial fraud and employment-related class actions. Possessing significant law and motion and trial experience, Mr. Greenstone has represented clients in multi-million dollar disputes in California state and federal courts, as well as the Court of Federal Claims in Washington, D.C. Mr. Greenstone received his training as an associate at Sheppard TRUTH-IN-LENDING ACT VIOLATIONS If you are a victim of fraudulent lending practices call our offices for a free and confidential claim review by a consumer class actionattorney.
APACHE CORPORATION
On April 23, 2019, pre-market, the Company announced that it had begun a "emporary" deferral of natural gas production at its Alpine High oil-and-gas resource play in the PermiCASEY E. SADLER
CASEY E. SADLER is a native of New York, New York. After graduating from the University of Southern California, Gould School of Law, Mr. Sadler joined the Firm in 2010. While attending law school, Mr. Sadler externed for the Enforcement Division of the Securities and Exchange Commission, spent a summer working for P.H. Parekh & Co. — one of the leading appellate law firms in New Delhi, India NATIONAL CLASS ACTION LAWYERS Glancy's class action lawyers litigate complex class action suits and individual claims against the world’s largest corporations in federal and state court. OUR TEAM | GLANCY PRONGAY & MURRAY LLP Attorney & Staff Search. Search By Name Search By letter. A B C D E F G H I J K L M N O P Q R S T U V W X Y ZSKILLZ INC.
On March 8, 2021, Wolfpack Research published a report about the Company alleging that the growth speculations from Skillz and its insiders were “entirely unrealistic” and thaATERIAN, INC.
On May 4, 2021, Culper Research published a report titled “Aterian (ATER): Bought from Felons & Fraudsters, Sold to You,” alleging that Aterian has “ties to convicted criminLIONEL Z. GLANCY
LIONEL Z. GLANCY, a graduate of University of Michigan Law School, is the founding partner of the Firm. After serving as a law clerk for United States District Judge Howard McKibben, he began his career as an associate at a New York law firm concentrating in securities litigation. Thereafter, he started a boutique law firm specializing in securities litigation, and other complex litigation CONTACT A TRADEMARK LITIGATION LAWYER FOR TRADEMARKSEE MORE ONGLANCYLAW.COM
MARK S. GREENSTONE
MARK S. GREENSTONE specializes in consumer, financial fraud and employment-related class actions. Possessing significant law and motion and trial experience, Mr. Greenstone has represented clients in multi-million dollar disputes in California state and federal courts, as well as the Court of Federal Claims in Washington, D.C. Mr. Greenstone received his training as an associate at Sheppard TRUTH-IN-LENDING ACT VIOLATIONS If you are a victim of fraudulent lending practices call our offices for a free and confidential claim review by a consumer class actionattorney.
APACHE CORPORATION
On April 23, 2019, pre-market, the Company announced that it had begun a "emporary" deferral of natural gas production at its Alpine High oil-and-gas resource play in the PermiCASEY E. SADLER
CASEY E. SADLER is a native of New York, New York. After graduating from the University of Southern California, Gould School of Law, Mr. Sadler joined the Firm in 2010. While attending law school, Mr. Sadler externed for the Enforcement Division of the Securities and Exchange Commission, spent a summer working for P.H. Parekh & Co. — one of the leading appellate law firms in New Delhi, India CONTACT US | GLANCY PRONGAY & MURRAY LLP Our Locations. Glancy Prongay & Murray LLP Los Angeles. 1925 Century Park East Suite 2100 Los Angeles, CA 90067. 310-201-9150 Phone 310-432-1495 Fax. info@glancylaw.com ACELRX PHARMACEUTICALS, INC. AcelRx is a pharmaceutical company that develops therapies for the treatment of acute pain. One of its lead product candidates is DSUVIA, which has been approved by the U.S. FoodOSCAR HEALTH, INC.
Oscar provides health insurance products and services to individuals, families, and businesses in the United States. The company was formerly known as Mulberry Health Inc. and cha IP LITIGATION LAWYERS Our IP litigation lawyers assist inventors, artists and businesses. We protect intellectual property rights such as copyrights, trade secrets, licensing agreements and patents. LINE | GLANCY PRONGAY & MURRAY LLP Have You Used the LINE Messenger App or the B612 App? Get Justice and Compensation Time Limited - Act Now Do you qualify? The LINE MessengerApp allowed a
9F INC. - GLANCY PRONGAY & MURRAY LLP In August 2019, 9F completed its initial public offering (“IPO”), selling approximately 8.9 million American Depositary Shares at $9.50 a share. On September 27, 2019, 9F repoIMMUNOMEDICS, INC.
On December 17, 2018, FDAnews published an article reporting that “he FDA cited Immunomedics for a host of violations – including its handling of a data integrity breach oCASEY E. SADLER
CASEY E. SADLER is a native of New York, New York. After graduating from the University of Southern California, Gould School of Law, Mr. Sadler joined the Firm in 2010. While attending law school, Mr. Sadler externed for the Enforcement Division of the Securities and Exchange Commission, spent a summer working for P.H. Parekh & Co. — one of the leading appellate law firms in New Delhi, IndiaJONATHAN M. ROTTER
JONATHAN M. ROTTER leads the Firm’s intellectual property litigation practice and has extensive experience in class action litigation, including in the fields of data privacy, digital content, securities, consumer protection, and antitrust. His cases often involve technical and scientific issues, and he excels at the critical skill of understanding and organizing complex subject matter in a MISAPPROPRIATION OF CORPORATE FUNDS Corporate officers and directors are not permitted to intentionally and illegally use corporate funds for personal gain or any other unauthorized purpose. NATIONAL CLASS ACTION LAWYERS With more than 25 years of experience litigating and winning cases on behalf of individuals, institutional investors, businesses, consumers, and employees, Glancy Prongay & Murray LLP (“GPM”) is recognized as one of the leading plaintiff’s law firms in the nation. Our team of highly qualified class action lawyers and research analysts OUR TEAM | GLANCY PRONGAY & MURRAY LLP Attorney & Staff Search. Search By Name Search By letter. A B C D E F G H I J K L M N O P Q R S T U V W X Y ZLIONEL Z. GLANCY
LIONEL Z. GLANCY, a graduate of University of Michigan Law School, is the founding partner of the Firm. After serving as a law clerk for United States District Judge Howard McKibben, he began his career as an associate at a New York law firm concentrating in securities litigation. Thereafter, he started a boutique law firm specializing in securities litigation, and other complex litigationATERIAN, INC.
Aterian, Inc. On May 4, 2021, Culper Research published a report titled “Aterian (ATER): Bought from Felons & Fraudsters, Sold to You,” alleging that Aterian has “ties to convicted criminals” and is “promoting what we believe is an overhyped ‘AI’ narrative and a string of garbage acquisitions to mask the failure of itsalready ill
SKILLZ INC.
On this news, Skillz stock price fell $3.00 per share, or 10.9%, to close at $24.45, thereby injuring investors. On April 19, 2021, Eagle Eye Research posted an anonymous report on Twitter in which it claimed that, through the use of providing users with incentive Bonus Payments, “the company likely recognizes substantial non-cashrevenue and
APACHE CORPORATION
On this news, Apache's stock price fell $1.16, or 5%, to close at $22.07 per share on October 25, 2019, thereby injuring investors. Then, on February 26, 2020, post-market, the Company announced that it was completely de-valuing Alpine High after taking a $3 billion write-down on the project. Two weeks later, on March 12, 2020, Apacheannounced
TRUTH-IN-LENDING ACT VIOLATIONS Truth-In-Lending Act Violations. The Truth in Lending Act (“TILA”) is a federal statute that protects consumers from confusing or deceitful lending practices. As a consumer, you have the right to detailed and clear disclosures from your lender, including: Amount ofTHOMAS J. KENNEDY
THOMAS J. KENNEDY works out of the New York office, where he specializes in securities, antitrust, and consumer litigation. He received a Juris Doctor degree from St. John’s University School of Law in 1995. At St. John’s, he was a member of the ST. JOHN’S JOURNAL OF LEGAL COMMENTARY. Mr. Kennedy graduated from Miami University in 1992 with a Bachelor of Science degree in Accounting andMARK S. GREENSTONE
MARK S. GREENSTONE specializes in consumer, financial fraud and employment-related class actions. Possessing significant law and motion and trial experience, Mr. Greenstone has represented clients in multi-million dollar disputes in California state and federal courts, as well as the Court of Federal Claims in Washington, D.C. Mr. Greenstone received his training as an associate at Sheppard MISAPPROPRIATION OF CORPORATE FUNDS Moreover, when a company’s executives misappropriated corporate funds, management’s positive statements regarding the company’s or its management’s honesty or integrity may be false. Such statements may too give rise to a securities fraud claim. Another possible action to take against insiders that misappropriated funds is the NATIONAL CLASS ACTION LAWYERS With more than 25 years of experience litigating and winning cases on behalf of individuals, institutional investors, businesses, consumers, and employees, Glancy Prongay & Murray LLP (“GPM”) is recognized as one of the leading plaintiff’s law firms in the nation. Our team of highly qualified class action lawyers and research analysts OUR TEAM | GLANCY PRONGAY & MURRAY LLP Attorney & Staff Search. Search By Name Search By letter. A B C D E F G H I J K L M N O P Q R S T U V W X Y ZLIONEL Z. GLANCY
LIONEL Z. GLANCY, a graduate of University of Michigan Law School, is the founding partner of the Firm. After serving as a law clerk for United States District Judge Howard McKibben, he began his career as an associate at a New York law firm concentrating in securities litigation. Thereafter, he started a boutique law firm specializing in securities litigation, and other complex litigationATERIAN, INC.
Aterian, Inc. On May 4, 2021, Culper Research published a report titled “Aterian (ATER): Bought from Felons & Fraudsters, Sold to You,” alleging that Aterian has “ties to convicted criminals” and is “promoting what we believe is an overhyped ‘AI’ narrative and a string of garbage acquisitions to mask the failure of itsalready ill
SKILLZ INC.
On this news, Skillz stock price fell $3.00 per share, or 10.9%, to close at $24.45, thereby injuring investors. On April 19, 2021, Eagle Eye Research posted an anonymous report on Twitter in which it claimed that, through the use of providing users with incentive Bonus Payments, “the company likely recognizes substantial non-cashrevenue and
APACHE CORPORATION
On this news, Apache's stock price fell $1.16, or 5%, to close at $22.07 per share on October 25, 2019, thereby injuring investors. Then, on February 26, 2020, post-market, the Company announced that it was completely de-valuing Alpine High after taking a $3 billion write-down on the project. Two weeks later, on March 12, 2020, Apacheannounced
TRUTH-IN-LENDING ACT VIOLATIONS Truth-In-Lending Act Violations. The Truth in Lending Act (“TILA”) is a federal statute that protects consumers from confusing or deceitful lending practices. As a consumer, you have the right to detailed and clear disclosures from your lender, including: Amount ofTHOMAS J. KENNEDY
THOMAS J. KENNEDY works out of the New York office, where he specializes in securities, antitrust, and consumer litigation. He received a Juris Doctor degree from St. John’s University School of Law in 1995. At St. John’s, he was a member of the ST. JOHN’S JOURNAL OF LEGAL COMMENTARY. Mr. Kennedy graduated from Miami University in 1992 with a Bachelor of Science degree in Accounting andMARK S. GREENSTONE
MARK S. GREENSTONE specializes in consumer, financial fraud and employment-related class actions. Possessing significant law and motion and trial experience, Mr. Greenstone has represented clients in multi-million dollar disputes in California state and federal courts, as well as the Court of Federal Claims in Washington, D.C. Mr. Greenstone received his training as an associate at Sheppard MISAPPROPRIATION OF CORPORATE FUNDS Moreover, when a company’s executives misappropriated corporate funds, management’s positive statements regarding the company’s or its management’s honesty or integrity may be false. Such statements may too give rise to a securities fraud claim. Another possible action to take against insiders that misappropriated funds is the ACELRX PHARMACEUTICALS, INC. AcelRx is a pharmaceutical company that develops therapies for the treatment of acute pain. One of its lead product candidates is DSUVIA, which has been approved by the U.S. Food CONTACT US | GLANCY PRONGAY & MURRAY LLP Our Locations. Glancy Prongay & Murray LLP Los Angeles. 1925 Century Park East Suite 2100 Los Angeles, CA 90067. 310-201-9150 Phone 310-432-1495 Fax. info@glancylaw.comRENOVACARE, INC.
On May 28, 2021, the United States Securities and Exchange Commission issued a litigation release stating that RenovaCare was being charged with alleged securities fraud. Accordin FREQUENCY THERAPEUTICS, INC. Frequency is a pharmaceutical company developing a hearing loss treatment titled “FX-322,” which the Company has long promoted as a potential treatment for patients with sever EMERGENT BIOSOLUTIONS INC. Emergent BioSolutions Inc. On March 31, 2021, The New York Times published an article reporting that in late February 2021, employees at Emergent’s Baltimore manufacturing plant “mixed up” ingredients of the different COVID-19 vaccines, contaminating up to 15 million doses of the Johnson & Johnson (“J&J”) vaccine forcingregulators to
CLASS ACTION ATTORNEYS We have a strong background in class action law and proven history of success for clients in complex litigation. Our attorneys are proud to stand by the people that we represent and dedicated to working aggressively to get them the full compensation available under the law. Call us at (310) 201-9150 or contact us online to speak with ourclass
IP LITIGATION LAWYERS IP Litigation Lawyers Protecting Intellectual Property Rights. Glancy Prongay & Murray LLP is committed to representing inventors, artists and businesses with intellectual property matters. Our IP litigation lawyers help you protect your intellectual property and are experienced in navigating highly technical patent practice. GPM’sattorneys
NEW YORK FIFTH AVENUE New York Securities Litigation Attorney Fifth Avenue 712 5th Avenue 31st Floor New York, NY 10019 Phone: 212-935-7400 toll-free: 877-935-7400 info@glancylaw.com New York Law Offices The attorneys at Glancy Prongay & Murray LLP have years of experience handling major litigation, including securities, antitrust, intellectual property, derivative, consumer products and employment casesFIBROGEN INC.
FibroGen, Inc. Stock Symbol. FGEN. On November 4, 2019, Plainview LLC (“Plainview”) published a report questioning the safety and efficacy of Fibrogen’s lead product candidate, Roxadustat. On this news, Fibrogen’s stock price fell $3.01 per share, or nearly 8%, to close at $37.01 per share on November 4, 2019, thereby injuringinvestors.
BENJAMIN I. SACHS-MICHAELS BENJAMIN I. SACHS-MICHAELS, a partner in the firm’s New York office, graduated from Benjamin N. Cardozo School of Law in 2011. His practice focuses on shareholder derivative litigation and class actions on behalf of shareholders and consumers. While in law school, Mr. Sachs-Michaels served as a judicial intern to Senior United States District Judge Thomas J. McAvoy in the United States NATIONAL CLASS ACTION LAWYERS With more than 25 years of experience litigating and winning cases on behalf of individuals, institutional investors, businesses, consumers, and employees, Glancy Prongay & Murray LLP (“GPM”) is recognized as one of the leading plaintiff’s law firms in the nation. Our team of highly qualified class action lawyers and research analysts OUR TEAM | GLANCY PRONGAY & MURRAY LLP Attorney & Staff Search. Search By Name Search By letter. A B C D E F G H I J K L M N O P Q R S T U V W X Y ZLIONEL Z. GLANCY
LIONEL Z. GLANCY, a graduate of University of Michigan Law School, is the founding partner of the Firm. After serving as a law clerk for United States District Judge Howard McKibben, he began his career as an associate at a New York law firm concentrating in securities litigation. Thereafter, he started a boutique law firm specializing in securities litigation, and other complex litigationATERIAN, INC.
Aterian, Inc. On May 4, 2021, Culper Research published a report titled “Aterian (ATER): Bought from Felons & Fraudsters, Sold to You,” alleging that Aterian has “ties to convicted criminals” and is “promoting what we believe is an overhyped ‘AI’ narrative and a string of garbage acquisitions to mask the failure of itsalready ill
SKILLZ INC.
On this news, Skillz stock price fell $3.00 per share, or 10.9%, to close at $24.45, thereby injuring investors. On April 19, 2021, Eagle Eye Research posted an anonymous report on Twitter in which it claimed that, through the use of providing users with incentive Bonus Payments, “the company likely recognizes substantial non-cashrevenue and
APACHE CORPORATION
On this news, Apache's stock price fell $1.16, or 5%, to close at $22.07 per share on October 25, 2019, thereby injuring investors. Then, on February 26, 2020, post-market, the Company announced that it was completely de-valuing Alpine High after taking a $3 billion write-down on the project. Two weeks later, on March 12, 2020, Apacheannounced
TRUTH-IN-LENDING ACT VIOLATIONS Truth-In-Lending Act Violations. The Truth in Lending Act (“TILA”) is a federal statute that protects consumers from confusing or deceitful lending practices. As a consumer, you have the right to detailed and clear disclosures from your lender, including: Amount ofTHOMAS J. KENNEDY
THOMAS J. KENNEDY works out of the New York office, where he specializes in securities, antitrust, and consumer litigation. He received a Juris Doctor degree from St. John’s University School of Law in 1995. At St. John’s, he was a member of the ST. JOHN’S JOURNAL OF LEGAL COMMENTARY. Mr. Kennedy graduated from Miami University in 1992 with a Bachelor of Science degree in Accounting andMARK S. GREENSTONE
MARK S. GREENSTONE specializes in consumer, financial fraud and employment-related class actions. Possessing significant law and motion and trial experience, Mr. Greenstone has represented clients in multi-million dollar disputes in California state and federal courts, as well as the Court of Federal Claims in Washington, D.C. Mr. Greenstone received his training as an associate at Sheppard MISAPPROPRIATION OF CORPORATE FUNDS Moreover, when a company’s executives misappropriated corporate funds, management’s positive statements regarding the company’s or its management’s honesty or integrity may be false. Such statements may too give rise to a securities fraud claim. Another possible action to take against insiders that misappropriated funds is the NATIONAL CLASS ACTION LAWYERS With more than 25 years of experience litigating and winning cases on behalf of individuals, institutional investors, businesses, consumers, and employees, Glancy Prongay & Murray LLP (“GPM”) is recognized as one of the leading plaintiff’s law firms in the nation. Our team of highly qualified class action lawyers and research analysts OUR TEAM | GLANCY PRONGAY & MURRAY LLP Attorney & Staff Search. Search By Name Search By letter. A B C D E F G H I J K L M N O P Q R S T U V W X Y ZLIONEL Z. GLANCY
LIONEL Z. GLANCY, a graduate of University of Michigan Law School, is the founding partner of the Firm. After serving as a law clerk for United States District Judge Howard McKibben, he began his career as an associate at a New York law firm concentrating in securities litigation. Thereafter, he started a boutique law firm specializing in securities litigation, and other complex litigationATERIAN, INC.
Aterian, Inc. On May 4, 2021, Culper Research published a report titled “Aterian (ATER): Bought from Felons & Fraudsters, Sold to You,” alleging that Aterian has “ties to convicted criminals” and is “promoting what we believe is an overhyped ‘AI’ narrative and a string of garbage acquisitions to mask the failure of itsalready ill
SKILLZ INC.
On this news, Skillz stock price fell $3.00 per share, or 10.9%, to close at $24.45, thereby injuring investors. On April 19, 2021, Eagle Eye Research posted an anonymous report on Twitter in which it claimed that, through the use of providing users with incentive Bonus Payments, “the company likely recognizes substantial non-cashrevenue and
APACHE CORPORATION
On this news, Apache's stock price fell $1.16, or 5%, to close at $22.07 per share on October 25, 2019, thereby injuring investors. Then, on February 26, 2020, post-market, the Company announced that it was completely de-valuing Alpine High after taking a $3 billion write-down on the project. Two weeks later, on March 12, 2020, Apacheannounced
TRUTH-IN-LENDING ACT VIOLATIONS Truth-In-Lending Act Violations. The Truth in Lending Act (“TILA”) is a federal statute that protects consumers from confusing or deceitful lending practices. As a consumer, you have the right to detailed and clear disclosures from your lender, including: Amount ofTHOMAS J. KENNEDY
THOMAS J. KENNEDY works out of the New York office, where he specializes in securities, antitrust, and consumer litigation. He received a Juris Doctor degree from St. John’s University School of Law in 1995. At St. John’s, he was a member of the ST. JOHN’S JOURNAL OF LEGAL COMMENTARY. Mr. Kennedy graduated from Miami University in 1992 with a Bachelor of Science degree in Accounting andMARK S. GREENSTONE
MARK S. GREENSTONE specializes in consumer, financial fraud and employment-related class actions. Possessing significant law and motion and trial experience, Mr. Greenstone has represented clients in multi-million dollar disputes in California state and federal courts, as well as the Court of Federal Claims in Washington, D.C. Mr. Greenstone received his training as an associate at Sheppard MISAPPROPRIATION OF CORPORATE FUNDS Moreover, when a company’s executives misappropriated corporate funds, management’s positive statements regarding the company’s or its management’s honesty or integrity may be false. Such statements may too give rise to a securities fraud claim. Another possible action to take against insiders that misappropriated funds is the ACELRX PHARMACEUTICALS, INC. AcelRx is a pharmaceutical company that develops therapies for the treatment of acute pain. One of its lead product candidates is DSUVIA, which has been approved by the U.S. Food CONTACT US | GLANCY PRONGAY & MURRAY LLP Our Locations. Glancy Prongay & Murray LLP Los Angeles. 1925 Century Park East Suite 2100 Los Angeles, CA 90067. 310-201-9150 Phone 310-432-1495 Fax. info@glancylaw.comRENOVACARE, INC.
On May 28, 2021, the United States Securities and Exchange Commission issued a litigation release stating that RenovaCare was being charged with alleged securities fraud. Accordin FREQUENCY THERAPEUTICS, INC. Frequency is a pharmaceutical company developing a hearing loss treatment titled “FX-322,” which the Company has long promoted as a potential treatment for patients with sever EMERGENT BIOSOLUTIONS INC. Emergent BioSolutions Inc. On March 31, 2021, The New York Times published an article reporting that in late February 2021, employees at Emergent’s Baltimore manufacturing plant “mixed up” ingredients of the different COVID-19 vaccines, contaminating up to 15 million doses of the Johnson & Johnson (“J&J”) vaccine forcingregulators to
CLASS ACTION ATTORNEYS We have a strong background in class action law and proven history of success for clients in complex litigation. Our attorneys are proud to stand by the people that we represent and dedicated to working aggressively to get them the full compensation available under the law. Call us at (310) 201-9150 or contact us online to speak with ourclass
IP LITIGATION LAWYERS IP Litigation Lawyers Protecting Intellectual Property Rights. Glancy Prongay & Murray LLP is committed to representing inventors, artists and businesses with intellectual property matters. Our IP litigation lawyers help you protect your intellectual property and are experienced in navigating highly technical patent practice. GPM’sattorneys
NEW YORK FIFTH AVENUE New York Securities Litigation Attorney Fifth Avenue 712 5th Avenue 31st Floor New York, NY 10019 Phone: 212-935-7400 toll-free: 877-935-7400 info@glancylaw.com New York Law Offices The attorneys at Glancy Prongay & Murray LLP have years of experience handling major litigation, including securities, antitrust, intellectual property, derivative, consumer products and employment casesFIBROGEN INC.
FibroGen, Inc. Stock Symbol. FGEN. On November 4, 2019, Plainview LLC (“Plainview”) published a report questioning the safety and efficacy of Fibrogen’s lead product candidate, Roxadustat. On this news, Fibrogen’s stock price fell $3.01 per share, or nearly 8%, to close at $37.01 per share on November 4, 2019, thereby injuringinvestors.
BENJAMIN I. SACHS-MICHAELS BENJAMIN I. SACHS-MICHAELS, a partner in the firm’s New York office, graduated from Benjamin N. Cardozo School of Law in 2011. His practice focuses on shareholder derivative litigation and class actions on behalf of shareholders and consumers. While in law school, Mr. Sachs-Michaels served as a judicial intern to Senior United States District Judge Thomas J. McAvoy in the United States NATIONAL CLASS ACTION LAWYERS With more than 25 years of experience litigating and winning cases on behalf of individuals, institutional investors, businesses, consumers, and employees, Glancy Prongay & Murray LLP (“GPM”) is recognized as one of the leading plaintiff’s law firms in the nation. Our team of highly qualified class action lawyers and research analysts OUR TEAM | GLANCY PRONGAY & MURRAY LLP Attorney & Staff Search. Search By Name Search By letter. A B C D E F G H I J K L M N O P Q R S T U V W X Y ZLIONEL Z. GLANCY
LIONEL Z. GLANCY, a graduate of University of Michigan Law School, is the founding partner of the Firm. After serving as a law clerk for United States District Judge Howard McKibben, he began his career as an associate at a New York law firm concentrating in securities litigation. Thereafter, he started a boutique law firm specializing in securities litigation, and other complex litigationATERIAN, INC.
Aterian, Inc. On May 4, 2021, Culper Research published a report titled “Aterian (ATER): Bought from Felons & Fraudsters, Sold to You,” alleging that Aterian has “ties to convicted criminals” and is “promoting what we believe is an overhyped ‘AI’ narrative and a string of garbage acquisitions to mask the failure of itsalready ill
SKILLZ INC.
On this news, Skillz stock price fell $3.00 per share, or 10.9%, to close at $24.45, thereby injuring investors. On April 19, 2021, Eagle Eye Research posted an anonymous report on Twitter in which it claimed that, through the use of providing users with incentive Bonus Payments, “the company likely recognizes substantial non-cashrevenue and
APACHE CORPORATION
On this news, Apache's stock price fell $1.16, or 5%, to close at $22.07 per share on October 25, 2019, thereby injuring investors. Then, on February 26, 2020, post-market, the Company announced that it was completely de-valuing Alpine High after taking a $3 billion write-down on the project. Two weeks later, on March 12, 2020, Apacheannounced
TRUTH-IN-LENDING ACT VIOLATIONS Truth-In-Lending Act Violations. The Truth in Lending Act (“TILA”) is a federal statute that protects consumers from confusing or deceitful lending practices. As a consumer, you have the right to detailed and clear disclosures from your lender, including: Amount ofTHOMAS J. KENNEDY
THOMAS J. KENNEDY works out of the New York office, where he specializes in securities, antitrust, and consumer litigation. He received a Juris Doctor degree from St. John’s University School of Law in 1995. At St. John’s, he was a member of the ST. JOHN’S JOURNAL OF LEGAL COMMENTARY. Mr. Kennedy graduated from Miami University in 1992 with a Bachelor of Science degree in Accounting andMARK S. GREENSTONE
MARK S. GREENSTONE specializes in consumer, financial fraud and employment-related class actions. Possessing significant law and motion and trial experience, Mr. Greenstone has represented clients in multi-million dollar disputes in California state and federal courts, as well as the Court of Federal Claims in Washington, D.C. Mr. Greenstone received his training as an associate at Sheppard MISAPPROPRIATION OF CORPORATE FUNDS Moreover, when a company’s executives misappropriated corporate funds, management’s positive statements regarding the company’s or its management’s honesty or integrity may be false. Such statements may too give rise to a securities fraud claim. Another possible action to take against insiders that misappropriated funds is the NATIONAL CLASS ACTION LAWYERS With more than 25 years of experience litigating and winning cases on behalf of individuals, institutional investors, businesses, consumers, and employees, Glancy Prongay & Murray LLP (“GPM”) is recognized as one of the leading plaintiff’s law firms in the nation. Our team of highly qualified class action lawyers and research analysts OUR TEAM | GLANCY PRONGAY & MURRAY LLP Attorney & Staff Search. Search By Name Search By letter. A B C D E F G H I J K L M N O P Q R S T U V W X Y ZLIONEL Z. GLANCY
LIONEL Z. GLANCY, a graduate of University of Michigan Law School, is the founding partner of the Firm. After serving as a law clerk for United States District Judge Howard McKibben, he began his career as an associate at a New York law firm concentrating in securities litigation. Thereafter, he started a boutique law firm specializing in securities litigation, and other complex litigationATERIAN, INC.
Aterian, Inc. On May 4, 2021, Culper Research published a report titled “Aterian (ATER): Bought from Felons & Fraudsters, Sold to You,” alleging that Aterian has “ties to convicted criminals” and is “promoting what we believe is an overhyped ‘AI’ narrative and a string of garbage acquisitions to mask the failure of itsalready ill
SKILLZ INC.
On this news, Skillz stock price fell $3.00 per share, or 10.9%, to close at $24.45, thereby injuring investors. On April 19, 2021, Eagle Eye Research posted an anonymous report on Twitter in which it claimed that, through the use of providing users with incentive Bonus Payments, “the company likely recognizes substantial non-cashrevenue and
APACHE CORPORATION
On this news, Apache's stock price fell $1.16, or 5%, to close at $22.07 per share on October 25, 2019, thereby injuring investors. Then, on February 26, 2020, post-market, the Company announced that it was completely de-valuing Alpine High after taking a $3 billion write-down on the project. Two weeks later, on March 12, 2020, Apacheannounced
TRUTH-IN-LENDING ACT VIOLATIONS Truth-In-Lending Act Violations. The Truth in Lending Act (“TILA”) is a federal statute that protects consumers from confusing or deceitful lending practices. As a consumer, you have the right to detailed and clear disclosures from your lender, including: Amount ofTHOMAS J. KENNEDY
THOMAS J. KENNEDY works out of the New York office, where he specializes in securities, antitrust, and consumer litigation. He received a Juris Doctor degree from St. John’s University School of Law in 1995. At St. John’s, he was a member of the ST. JOHN’S JOURNAL OF LEGAL COMMENTARY. Mr. Kennedy graduated from Miami University in 1992 with a Bachelor of Science degree in Accounting andMARK S. GREENSTONE
MARK S. GREENSTONE specializes in consumer, financial fraud and employment-related class actions. Possessing significant law and motion and trial experience, Mr. Greenstone has represented clients in multi-million dollar disputes in California state and federal courts, as well as the Court of Federal Claims in Washington, D.C. Mr. Greenstone received his training as an associate at Sheppard MISAPPROPRIATION OF CORPORATE FUNDS Moreover, when a company’s executives misappropriated corporate funds, management’s positive statements regarding the company’s or its management’s honesty or integrity may be false. Such statements may too give rise to a securities fraud claim. Another possible action to take against insiders that misappropriated funds is the ACELRX PHARMACEUTICALS, INC. AcelRx is a pharmaceutical company that develops therapies for the treatment of acute pain. One of its lead product candidates is DSUVIA, which has been approved by the U.S. Food CONTACT US | GLANCY PRONGAY & MURRAY LLP Our Locations. Glancy Prongay & Murray LLP Los Angeles. 1925 Century Park East Suite 2100 Los Angeles, CA 90067. 310-201-9150 Phone 310-432-1495 Fax. info@glancylaw.comRENOVACARE, INC.
On May 28, 2021, the United States Securities and Exchange Commission issued a litigation release stating that RenovaCare was being charged with alleged securities fraud. Accordin FREQUENCY THERAPEUTICS, INC. Frequency is a pharmaceutical company developing a hearing loss treatment titled “FX-322,” which the Company has long promoted as a potential treatment for patients with sever EMERGENT BIOSOLUTIONS INC. Emergent BioSolutions Inc. On March 31, 2021, The New York Times published an article reporting that in late February 2021, employees at Emergent’s Baltimore manufacturing plant “mixed up” ingredients of the different COVID-19 vaccines, contaminating up to 15 million doses of the Johnson & Johnson (“J&J”) vaccine forcingregulators to
CLASS ACTION ATTORNEYS We have a strong background in class action law and proven history of success for clients in complex litigation. Our attorneys are proud to stand by the people that we represent and dedicated to working aggressively to get them the full compensation available under the law. Call us at (310) 201-9150 or contact us online to speak with ourclass
IP LITIGATION LAWYERS IP Litigation Lawyers Protecting Intellectual Property Rights. Glancy Prongay & Murray LLP is committed to representing inventors, artists and businesses with intellectual property matters. Our IP litigation lawyers help you protect your intellectual property and are experienced in navigating highly technical patent practice. GPM’sattorneys
NEW YORK FIFTH AVENUE New York Securities Litigation Attorney Fifth Avenue 712 5th Avenue 31st Floor New York, NY 10019 Phone: 212-935-7400 toll-free: 877-935-7400 info@glancylaw.com New York Law Offices The attorneys at Glancy Prongay & Murray LLP have years of experience handling major litigation, including securities, antitrust, intellectual property, derivative, consumer products and employment casesFIBROGEN INC.
FibroGen, Inc. Stock Symbol. FGEN. On November 4, 2019, Plainview LLC (“Plainview”) published a report questioning the safety and efficacy of Fibrogen’s lead product candidate, Roxadustat. On this news, Fibrogen’s stock price fell $3.01 per share, or nearly 8%, to close at $37.01 per share on November 4, 2019, thereby injuringinvestors.
BENJAMIN I. SACHS-MICHAELS BENJAMIN I. SACHS-MICHAELS, a partner in the firm’s New York office, graduated from Benjamin N. Cardozo School of Law in 2011. His practice focuses on shareholder derivative litigation and class actions on behalf of shareholders and consumers. While in law school, Mr. Sachs-Michaels served as a judicial intern to Senior United States District Judge Thomas J. McAvoy in the United States NATIONAL CLASS ACTION LAWYERS With more than 25 years of experience litigating and winning cases on behalf of individuals, institutional investors, businesses, consumers, and employees, Glancy Prongay & Murray LLP (“GPM”) is recognized as one of the leading plaintiff’s law firms in the nation. Our team of highly qualified class action lawyers and research analysts OUR TEAM | GLANCY PRONGAY & MURRAY LLP Attorney & Staff Search. Search By Name Search By letter. A B C D E F G H I J K L M N O P Q R S T U V W X Y ZLIONEL Z. GLANCY
LIONEL Z. GLANCY, a graduate of University of Michigan Law School, is the founding partner of the Firm. After serving as a law clerk for United States District Judge Howard McKibben, he began his career as an associate at a New York law firm concentrating in securities litigation. Thereafter, he started a boutique law firm specializing in securities litigation, and other complex litigationATERIAN, INC.
Aterian, Inc. On May 4, 2021, Culper Research published a report titled “Aterian (ATER): Bought from Felons & Fraudsters, Sold to You,” alleging that Aterian has “ties to convicted criminals” and is “promoting what we believe is an overhyped ‘AI’ narrative and a string of garbage acquisitions to mask the failure of itsalready ill
NEW YORK FIFTH AVENUE New York Securities Litigation Attorney Fifth Avenue 712 5th Avenue 31st Floor New York, NY 10019 Phone: 212-935-7400 toll-free: 877-935-7400 info@glancylaw.com New York Law Offices The attorneys at Glancy Prongay & Murray LLP have years of experience handling major litigation, including securities, antitrust, intellectual property, derivative, consumer products and employment cases EMERGENT BIOSOLUTIONS INC. Emergent BioSolutions Inc. On March 31, 2021, The New York Times published an article reporting that in late February 2021, employees at Emergent’s Baltimore manufacturing plant “mixed up” ingredients of the different COVID-19 vaccines, contaminating up to 15 million doses of the Johnson & Johnson (“J&J”) vaccine forcingregulators to
TRUTH-IN-LENDING ACT VIOLATIONS Truth-In-Lending Act Violations. The Truth in Lending Act (“TILA”) is a federal statute that protects consumers from confusing or deceitful lending practices. As a consumer, you have the right to detailed and clear disclosures from your lender, including: Amount ofMARK S. GREENSTONE
MARK S. GREENSTONE specializes in consumer, financial fraud and employment-related class actions. Possessing significant law and motion and trial experience, Mr. Greenstone has represented clients in multi-million dollar disputes in California state and federal courts, as well as the Court of Federal Claims in Washington, D.C. Mr. Greenstone received his training as an associate at SheppardLIFEMD, INC.
Specifically, according to Culper Research, “many customers are effectively duped into purchasing subscriptions rather than one-time purchases” and LifeMD “makes cancellations difficult if not impossible.”. On this news, the Company’s share price fell $2.84, or 24%, to close at $9.00 per share on April 14, 2021, on unusuallyheavy
GREGORY B. LINKH
GREGORY B. LINKH works out of the New York office, where he specializes in securities, shareholder derivative, antitrust, and consumer litigation. Greg graduated from the State University of New York at Binghamton in 1996 and from the University of Michigan Law School in 1999. While in law school, Greg externed with United States District Judge Gerald E. Rosen of the Eastern District of NATIONAL CLASS ACTION LAWYERS With more than 25 years of experience litigating and winning cases on behalf of individuals, institutional investors, businesses, consumers, and employees, Glancy Prongay & Murray LLP (“GPM”) is recognized as one of the leading plaintiff’s law firms in the nation. Our team of highly qualified class action lawyers and research analysts OUR TEAM | GLANCY PRONGAY & MURRAY LLP Attorney & Staff Search. Search By Name Search By letter. A B C D E F G H I J K L M N O P Q R S T U V W X Y ZLIONEL Z. GLANCY
LIONEL Z. GLANCY, a graduate of University of Michigan Law School, is the founding partner of the Firm. After serving as a law clerk for United States District Judge Howard McKibben, he began his career as an associate at a New York law firm concentrating in securities litigation. Thereafter, he started a boutique law firm specializing in securities litigation, and other complex litigationATERIAN, INC.
Aterian, Inc. On May 4, 2021, Culper Research published a report titled “Aterian (ATER): Bought from Felons & Fraudsters, Sold to You,” alleging that Aterian has “ties to convicted criminals” and is “promoting what we believe is an overhyped ‘AI’ narrative and a string of garbage acquisitions to mask the failure of itsalready ill
NEW YORK FIFTH AVENUE New York Securities Litigation Attorney Fifth Avenue 712 5th Avenue 31st Floor New York, NY 10019 Phone: 212-935-7400 toll-free: 877-935-7400 info@glancylaw.com New York Law Offices The attorneys at Glancy Prongay & Murray LLP have years of experience handling major litigation, including securities, antitrust, intellectual property, derivative, consumer products and employment cases EMERGENT BIOSOLUTIONS INC. Emergent BioSolutions Inc. On March 31, 2021, The New York Times published an article reporting that in late February 2021, employees at Emergent’s Baltimore manufacturing plant “mixed up” ingredients of the different COVID-19 vaccines, contaminating up to 15 million doses of the Johnson & Johnson (“J&J”) vaccine forcingregulators to
TRUTH-IN-LENDING ACT VIOLATIONS Truth-In-Lending Act Violations. The Truth in Lending Act (“TILA”) is a federal statute that protects consumers from confusing or deceitful lending practices. As a consumer, you have the right to detailed and clear disclosures from your lender, including: Amount ofMARK S. GREENSTONE
MARK S. GREENSTONE specializes in consumer, financial fraud and employment-related class actions. Possessing significant law and motion and trial experience, Mr. Greenstone has represented clients in multi-million dollar disputes in California state and federal courts, as well as the Court of Federal Claims in Washington, D.C. Mr. Greenstone received his training as an associate at SheppardLIFEMD, INC.
Specifically, according to Culper Research, “many customers are effectively duped into purchasing subscriptions rather than one-time purchases” and LifeMD “makes cancellations difficult if not impossible.”. On this news, the Company’s share price fell $2.84, or 24%, to close at $9.00 per share on April 14, 2021, on unusuallyheavy
GREGORY B. LINKH
GREGORY B. LINKH works out of the New York office, where he specializes in securities, shareholder derivative, antitrust, and consumer litigation. Greg graduated from the State University of New York at Binghamton in 1996 and from the University of Michigan Law School in 1999. While in law school, Greg externed with United States District Judge Gerald E. Rosen of the Eastern District of CONTACT US | GLANCY PRONGAY & MURRAY LLP Our Locations. Glancy Prongay & Murray LLP Los Angeles. 1925 Century Park East Suite 2100 Los Angeles, CA 90067. 310-201-9150 Phone 310-432-1495 Fax. info@glancylaw.com ACELRX PHARMACEUTICALS, INC. AcelRx is a pharmaceutical company that develops therapies for the treatment of acute pain. One of its lead product candidates is DSUVIA, which has been approved by the U.S. FoodRENOVACARE, INC.
On May 28, 2021, the United States Securities and Exchange Commission issued a litigation release stating that RenovaCare was being charged with alleged securities fraud. Accordin FREQUENCY THERAPEUTICS, INC. Frequency is a pharmaceutical company developing a hearing loss treatment titled “FX-322,” which the Company has long promoted as a potential treatment for patients with sever IP LITIGATION LAWYERS IP Litigation Lawyers Protecting Intellectual Property Rights. Glancy Prongay & Murray LLP is committed to representing inventors, artists and businesses with intellectual property matters. Our IP litigation lawyers help you protect your intellectual property and are experienced in navigating highly technical patent practice. GPM’sattorneys
SOS LIMITED
SOS Limited. On February 26, 2021, Hindenburg Research (“Hindenburg”) and Culper Research published reports regarding SOS, alleging that the Company was a "pump and dump" scheme that used fake addresses and doctored photos of crypto miners to create an illusion of success. The reports pointed out that SOS lists a hotelroom as the company
SKILLZ INC.
On this news, Skillz stock price fell $3.00 per share, or 10.9%, to close at $24.45, thereby injuring investors. On April 19, 2021, Eagle Eye Research posted an anonymous report on Twitter in which it claimed that, through the use of providing users with incentive Bonus Payments, “the company likely recognizes substantial non-cashrevenue and
LIFEMD, INC.
Specifically, according to Culper Research, “many customers are effectively duped into purchasing subscriptions rather than one-time purchases” and LifeMD “makes cancellations difficult if not impossible.”. On this news, the Company’s share price fell $2.84, or 24%, to close at $9.00 per share on April 14, 2021, on unusuallyheavy
MISAPPROPRIATION OF CORPORATE FUNDS Moreover, when a company’s executives misappropriated corporate funds, management’s positive statements regarding the company’s or its management’s honesty or integrity may be false. Such statements may too give rise to a securities fraud claim. Another possible action to take against insiders that misappropriated funds is theJONATHAN M. ROTTER
JONATHAN M. ROTTER leads the Firm’s intellectual property litigation practice and has extensive experience in class action litigation, including in the fields of data privacy, digital content, securities, consumer protection, and antitrust. His cases often involve technical and scientific issues, and he excels at the critical skill of understanding and organizing complex subject matter in a NATIONAL CLASS ACTION LAWYERS Glancy's class action lawyers litigate complex class action suits and individual claims against the world’s largest corporations in federal and state court. OUR TEAM | GLANCY PRONGAY & MURRAY LLP Attorney & Staff Search. Search By Name Search By letter. A B C D E F G H I J K L M N O P Q R S T U V W X Y Z CONTACT US | GLANCY PRONGAY & MURRAY LLP Our Locations. Glancy Prongay & Murray LLP Los Angeles. 1925 Century Park East Suite 2100 Los Angeles, CA 90067. 310-201-9150 Phone 310-432-1495 Fax. info@glancylaw.comLIONEL Z. GLANCY
LIONEL Z. GLANCY, a graduate of University of Michigan Law School, is the founding partner of the Firm. After serving as a law clerk for United States District Judge Howard McKibben, he began his career as an associate at a New York law firm concentrating in securities litigation. Thereafter, he started a boutique law firm specializing in securities litigation, and other complex litigation EMERGENT BIOSOLUTIONS INC. Emergent BioSolutions Inc. On March 31, 2021, The New York Times published an article reporting that in late February 2021, employees at Emergent’s Baltimore manufacturing plant “mixed up” ingredients of the different COVID-19 vaccines, contaminating up to 15 million doses of the Johnson & Johnson (“J&J”) vaccine forcingregulators to
NEW YORK FIFTH AVENUE New York Securities Litigation Attorney Fifth Avenue 712 5th Avenue 31st Floor New York, NY 10019 Phone: 212-935-7400 toll-free: 877-935-7400 info@glancylaw.com New York Law Offices The attorneys at Glancy Prongay & Murray LLP have years of experience handling major litigation, including securities, antitrust, intellectual property, derivative, consumer products and employment casesFIBROGEN INC.
FibroGen, Inc. Stock Symbol. FGEN. On November 4, 2019, Plainview LLC (“Plainview”) published a report questioning the safety and efficacy of Fibrogen’s lead product candidate, Roxadustat. On this news, Fibrogen’s stock price fell $3.01 per share, or nearly 8%, to close at $37.01 per share on November 4, 2019, thereby injuringinvestors.
THOMAS J. KENNEDY
THOMAS J. KENNEDY works out of the New York office, where he specializes in securities, antitrust, and consumer litigation. He received a Juris Doctor degree from St. John’s University School of Law in 1995. At St. John’s, he was a member of the ST. JOHN’S JOURNAL OF LEGAL COMMENTARY. Mr. Kennedy graduated from Miami University in 1992 with a Bachelor of Science degree in Accounting and MISAPPROPRIATION OF CORPORATE FUNDS Moreover, when a company’s executives misappropriated corporate funds, management’s positive statements regarding the company’s or its management’s honesty or integrity may be false. Such statements may too give rise to a securities fraud claim. Another possible action to take against insiders that misappropriated funds is theGREGORY B. LINKH
GREGORY B. LINKH works out of the New York office, where he specializes in securities, shareholder derivative, antitrust, and consumer litigation. Greg graduated from the State University of New York at Binghamton in 1996 and from the University of Michigan Law School in 1999. While in law school, Greg externed with United States District Judge Gerald E. Rosen of the Eastern District of NATIONAL CLASS ACTION LAWYERS Glancy's class action lawyers litigate complex class action suits and individual claims against the world’s largest corporations in federal and state court. OUR TEAM | GLANCY PRONGAY & MURRAY LLP Attorney & Staff Search. Search By Name Search By letter. A B C D E F G H I J K L M N O P Q R S T U V W X Y Z CONTACT US | GLANCY PRONGAY & MURRAY LLP Our Locations. Glancy Prongay & Murray LLP Los Angeles. 1925 Century Park East Suite 2100 Los Angeles, CA 90067. 310-201-9150 Phone 310-432-1495 Fax. info@glancylaw.comLIONEL Z. GLANCY
LIONEL Z. GLANCY, a graduate of University of Michigan Law School, is the founding partner of the Firm. After serving as a law clerk for United States District Judge Howard McKibben, he began his career as an associate at a New York law firm concentrating in securities litigation. Thereafter, he started a boutique law firm specializing in securities litigation, and other complex litigation EMERGENT BIOSOLUTIONS INC. Emergent BioSolutions Inc. On March 31, 2021, The New York Times published an article reporting that in late February 2021, employees at Emergent’s Baltimore manufacturing plant “mixed up” ingredients of the different COVID-19 vaccines, contaminating up to 15 million doses of the Johnson & Johnson (“J&J”) vaccine forcingregulators to
NEW YORK FIFTH AVENUE New York Securities Litigation Attorney Fifth Avenue 712 5th Avenue 31st Floor New York, NY 10019 Phone: 212-935-7400 toll-free: 877-935-7400 info@glancylaw.com New York Law Offices The attorneys at Glancy Prongay & Murray LLP have years of experience handling major litigation, including securities, antitrust, intellectual property, derivative, consumer products and employment casesFIBROGEN INC.
FibroGen, Inc. Stock Symbol. FGEN. On November 4, 2019, Plainview LLC (“Plainview”) published a report questioning the safety and efficacy of Fibrogen’s lead product candidate, Roxadustat. On this news, Fibrogen’s stock price fell $3.01 per share, or nearly 8%, to close at $37.01 per share on November 4, 2019, thereby injuringinvestors.
THOMAS J. KENNEDY
THOMAS J. KENNEDY works out of the New York office, where he specializes in securities, antitrust, and consumer litigation. He received a Juris Doctor degree from St. John’s University School of Law in 1995. At St. John’s, he was a member of the ST. JOHN’S JOURNAL OF LEGAL COMMENTARY. Mr. Kennedy graduated from Miami University in 1992 with a Bachelor of Science degree in Accounting and MISAPPROPRIATION OF CORPORATE FUNDS Moreover, when a company’s executives misappropriated corporate funds, management’s positive statements regarding the company’s or its management’s honesty or integrity may be false. Such statements may too give rise to a securities fraud claim. Another possible action to take against insiders that misappropriated funds is theGREGORY B. LINKH
GREGORY B. LINKH works out of the New York office, where he specializes in securities, shareholder derivative, antitrust, and consumer litigation. Greg graduated from the State University of New York at Binghamton in 1996 and from the University of Michigan Law School in 1999. While in law school, Greg externed with United States District Judge Gerald E. Rosen of the Eastern District of CONTACT US | GLANCY PRONGAY & MURRAY LLP Our Locations. Glancy Prongay & Murray LLP Los Angeles. 1925 Century Park East Suite 2100 Los Angeles, CA 90067. 310-201-9150 Phone 310-432-1495 Fax. info@glancylaw.comREKOR SYSTEMS, INC.
Submit Your Information. If you suffered a loss on your Rekor Systems, Inc. investments or would like to inquire about joining an action to recover your loss under the federal secSKILLZ INC.
On this news, Skillz stock price fell $3.00 per share, or 10.9%, to close at $24.45, thereby injuring investors. On April 19, 2021, Eagle Eye Research posted an anonymous report on Twitter in which it claimed that, through the use of providing users with incentive Bonus Payments, “the company likely recognizes substantial non-cashrevenue and
IP LITIGATION LAWYERS IP Litigation Lawyers Protecting Intellectual Property Rights. Glancy Prongay & Murray LLP is committed to representing inventors, artists and businesses with intellectual property matters. Our IP litigation lawyers help you protect your intellectual property and are experienced in navigating highly technical patent practice. GPM’sattorneys
FIBROGEN INC.
FibroGen, Inc. Stock Symbol. FGEN. On November 4, 2019, Plainview LLC (“Plainview”) published a report questioning the safety and efficacy of Fibrogen’s lead product candidate, Roxadustat. On this news, Fibrogen’s stock price fell $3.01 per share, or nearly 8%, to close at $37.01 per share on November 4, 2019, thereby injuringinvestors.
APACHE CORPORATION
On this news, Apache's stock price fell $1.16, or 5%, to close at $22.07 per share on October 25, 2019, thereby injuring investors. Then, on February 26, 2020, post-market, the Company announced that it was completely de-valuing Alpine High after taking a $3 billion write-down on the project. Two weeks later, on March 12, 2020, Apacheannounced
LIFEMD, INC.
Specifically, according to Culper Research, “many customers are effectively duped into purchasing subscriptions rather than one-time purchases” and LifeMD “makes cancellations difficult if not impossible.”. On this news, the Company’s share price fell $2.84, or 24%, to close at $9.00 per share on April 14, 2021, on unusuallyheavy
9F INC. - GLANCY PRONGAY & MURRAY LLP In August 2019, 9F completed its initial public offering (“IPO”), selling approximately 8.9 million American Depositary Shares at $9.50 a share. On September 27, 2019, 9F repoCASEY E. SADLER
CASEY E. SADLER is a native of New York, New York. After graduating from the University of Southern California, Gould School of Law, Mr. Sadler joined the Firm in 2010. While attending law school, Mr. Sadler externed for the Enforcement Division of the Securities and Exchange Commission, spent a summer working for P.H. Parekh & Co. — one of the leading appellate law firms in New Delhi, IndiaIMMUNOMEDICS, INC.
Immunomedics, Inc. On December 17, 2018, FDAnews published an article reporting that “ he FDA cited Immunomedics for a host of violations – including its handling of a data integrity breach – observed at its Morris Plains, New Jersey, drug substance manufacturing facility between August 6 and 14.”. The article further reported that NATIONAL CLASS ACTION LAWYERS Glancy's class action lawyers litigate complex class action suits and individual claims against the world’s largest corporations in federal and state court. OUR TEAM | GLANCY PRONGAY & MURRAY LLPGLANCY PRONGAY MURRAY LLPGLANCYLAW
Attorney & Staff Search. Search By Name Search By letter. A B C D E F G H I J K L M N O P Q R S T U V W X Y ZLIONEL Z. GLANCY
LIONEL Z. GLANCY, a graduate of University of Michigan Law School, is the founding partner of the Firm. After serving as a law clerk for United States District Judge Howard McKibben, he began his career as an associate at a New York law firm concentrating in securities litigation. Thereafter, he started a boutique law firm specializing in securities litigation, and other complex litigation EMERGENT BIOSOLUTIONS INC. Emergent BioSolutions Inc. On March 31, 2021, The New York Times published an article reporting that in late February 2021, employees at Emergent’s Baltimore manufacturing plant “mixed up” ingredients of the different COVID-19 vaccines, contaminating up to 15 million doses of the Johnson & Johnson (“J&J”) vaccine forcingregulators to
MARK S. GREENSTONE
MARK S. GREENSTONE specializes in consumer, financial fraud and employment-related class actions. Possessing significant law and motion and trial experience, Mr. Greenstone has represented clients in multi-million dollar disputes in California state and federal courts, as well as the Court of Federal Claims in Washington, D.C. Mr. Greenstone received his training as an associate at Sheppard TRUTH-IN-LENDING ACT VIOLATIONS Truth-In-Lending Act Violations. The Truth in Lending Act (“TILA”) is a federal statute that protects consumers from confusing or deceitful lending practices. As a consumer, you have the right to detailed and clear disclosures from your lender, including: Amount of NEW YORK FIFTH AVENUE New York Securities Litigation Attorney Fifth Avenue 712 5th Avenue 31st Floor New York, NY 10019 Phone: 212-935-7400 toll-free: 877-935-7400 info@glancylaw.com New York Law Offices The attorneys at Glancy Prongay & Murray LLP have years of experience handling major litigation, including securities, antitrust, intellectual property, derivative, consumer products and employment casesLIFEMD, INC.
Specifically, according to Culper Research, “many customers are effectively duped into purchasing subscriptions rather than one-time purchases” and LifeMD “makes cancellations difficult if not impossible.”. On this news, the Company’s share price fell $2.84, or 24%, to close at $9.00 per share on April 14, 2021, on unusuallyheavy
GREGORY B. LINKH
GREGORY B. LINKH works out of the New York office, where he specializes in securities, shareholder derivative, antitrust, and consumer litigation. Greg graduated from the State University of New York at Binghamton in 1996 and from the University of Michigan Law School in 1999. While in law school, Greg externed with United States District Judge Gerald E. Rosen of the Eastern District of TWITTER DERIVATIVE SETTLEMENT (RE PLAINTIFF ATUL VERMA ATUL VERMA, derivatively on behalf of. Nominal Defendant, TWITTER, INC., Plaintiff, v. RICHARD COSTOLO, ANTHONY. NOTO, JACK DORSEY, MARJORIE. SCARDINO, DAVID NATIONAL CLASS ACTION LAWYERS Glancy's class action lawyers litigate complex class action suits and individual claims against the world’s largest corporations in federal and state court. OUR TEAM | GLANCY PRONGAY & MURRAY LLPGLANCY PRONGAY MURRAY LLPGLANCYLAW
Attorney & Staff Search. Search By Name Search By letter. A B C D E F G H I J K L M N O P Q R S T U V W X Y ZLIONEL Z. GLANCY
LIONEL Z. GLANCY, a graduate of University of Michigan Law School, is the founding partner of the Firm. After serving as a law clerk for United States District Judge Howard McKibben, he began his career as an associate at a New York law firm concentrating in securities litigation. Thereafter, he started a boutique law firm specializing in securities litigation, and other complex litigation EMERGENT BIOSOLUTIONS INC. Emergent BioSolutions Inc. On March 31, 2021, The New York Times published an article reporting that in late February 2021, employees at Emergent’s Baltimore manufacturing plant “mixed up” ingredients of the different COVID-19 vaccines, contaminating up to 15 million doses of the Johnson & Johnson (“J&J”) vaccine forcingregulators to
MARK S. GREENSTONE
MARK S. GREENSTONE specializes in consumer, financial fraud and employment-related class actions. Possessing significant law and motion and trial experience, Mr. Greenstone has represented clients in multi-million dollar disputes in California state and federal courts, as well as the Court of Federal Claims in Washington, D.C. Mr. Greenstone received his training as an associate at Sheppard TRUTH-IN-LENDING ACT VIOLATIONS Truth-In-Lending Act Violations. The Truth in Lending Act (“TILA”) is a federal statute that protects consumers from confusing or deceitful lending practices. As a consumer, you have the right to detailed and clear disclosures from your lender, including: Amount of NEW YORK FIFTH AVENUE New York Securities Litigation Attorney Fifth Avenue 712 5th Avenue 31st Floor New York, NY 10019 Phone: 212-935-7400 toll-free: 877-935-7400 info@glancylaw.com New York Law Offices The attorneys at Glancy Prongay & Murray LLP have years of experience handling major litigation, including securities, antitrust, intellectual property, derivative, consumer products and employment casesLIFEMD, INC.
Specifically, according to Culper Research, “many customers are effectively duped into purchasing subscriptions rather than one-time purchases” and LifeMD “makes cancellations difficult if not impossible.”. On this news, the Company’s share price fell $2.84, or 24%, to close at $9.00 per share on April 14, 2021, on unusuallyheavy
GREGORY B. LINKH
GREGORY B. LINKH works out of the New York office, where he specializes in securities, shareholder derivative, antitrust, and consumer litigation. Greg graduated from the State University of New York at Binghamton in 1996 and from the University of Michigan Law School in 1999. While in law school, Greg externed with United States District Judge Gerald E. Rosen of the Eastern District of TWITTER DERIVATIVE SETTLEMENT (RE PLAINTIFF ATUL VERMA ATUL VERMA, derivatively on behalf of. Nominal Defendant, TWITTER, INC., Plaintiff, v. RICHARD COSTOLO, ANTHONY. NOTO, JACK DORSEY, MARJORIE. SCARDINO, DAVID CONTACT US | GLANCY PRONGAY & MURRAY LLP Our Locations. Glancy Prongay & Murray LLP Los Angeles. 1925 Century Park East Suite 2100 Los Angeles, CA 90067. 310-201-9150 Phone 310-432-1495 Fax. info@glancylaw.comATERIAN, INC.
Aterian, Inc. On May 4, 2021, Culper Research published a report titled “Aterian (ATER): Bought from Felons & Fraudsters, Sold to You,” alleging that Aterian has “ties to convicted criminals” and is “promoting what we believe is an overhyped ‘AI’ narrative and a string of garbage acquisitions to mask the failure of itsalready ill
REKOR SYSTEMS, INC.
Submit Your Information. If you suffered a loss on your Rekor Systems, Inc. investments or would like to inquire about joining an action to recover your loss under the federal secSKILLZ INC.
On this news, Skillz stock price fell $3.00 per share, or 10.9%, to close at $24.45, thereby injuring investors. On April 19, 2021, Eagle Eye Research posted an anonymous report on Twitter in which it claimed that, through the use of providing users with incentive Bonus Payments, “the company likely recognizes substantial non-cashrevenue and
SOS LIMITED
SOS Limited. On February 26, 2021, Hindenburg Research (“Hindenburg”) and Culper Research published reports regarding SOS, alleging that the Company was a "pump and dump" scheme that used fake addresses and doctored photos of crypto miners to create an illusion of success. The reports pointed out that SOS lists a hotelroom as the company
PURECYCLE TECHNOLOGIES, INC. PureCycle Technologies, Inc. On May 6, 2021, before the market opened, Hindenburg Research issued a report alleging that PureCycle is “another quintessential example of how executives and SPAC sponsors enrich themselves while hoisting unproven technology and ridiculous financial projections onto the public markets, leaving retailinvestors to
FIBROGEN INC.
FibroGen, Inc. Stock Symbol. FGEN. On November 4, 2019, Plainview LLC (“Plainview”) published a report questioning the safety and efficacy of Fibrogen’s lead product candidate, Roxadustat. On this news, Fibrogen’s stock price fell $3.01 per share, or nearly 8%, to close at $37.01 per share on November 4, 2019, thereby injuringinvestors.
THOMAS J. KENNEDY
THOMAS J. KENNEDY works out of the New York office, where he specializes in securities, antitrust, and consumer litigation. He received a Juris Doctor degree from St. John’s University School of Law in 1995. At St. John’s, he was a member of the ST. JOHN’S JOURNAL OF LEGAL COMMENTARY. Mr. Kennedy graduated from Miami University in 1992 with a Bachelor of Science degree in Accounting andIMMUNOMEDICS, INC.
Immunomedics, Inc. On December 17, 2018, FDAnews published an article reporting that “ he FDA cited Immunomedics for a host of violations – including its handling of a data integrity breach – observed at its Morris Plains, New Jersey, drug substance manufacturing facility between August 6 and 14.”. The article further reported that MISAPPROPRIATION OF CORPORATE FUNDS Moreover, when a company’s executives misappropriated corporate funds, management’s positive statements regarding the company’s or its management’s honesty or integrity may be false. Such statements may too give rise to a securities fraud claim. Another possible action to take against insiders that misappropriated funds is the NATIONAL CLASS ACTION LAWYERS Glancy's class action lawyers litigate complex class action suits and individual claims against the world’s largest corporations in federal and state court. OUR TEAM | GLANCY PRONGAY & MURRAY LLPGLANCY PRONGAY MURRAY LLPGLANCYLAW
Attorney & Staff Search. Search By Name Search By letter. A B C D E F G H I J K L M N O P Q R S T U V W X Y Z CONTACT US | GLANCY PRONGAY & MURRAY LLPGLANCY PRONGAY MURRAYLLPGLANCY LAW
Our Locations. Glancy Prongay & Murray LLP Los Angeles. 1925 Century Park East Suite 2100 Los Angeles, CA 90067. 310-201-9150 Phone 310-432-1495 Fax. info@glancylaw.comLIONEL Z. GLANCY
LIONEL Z. GLANCY, a graduate of University of Michigan Law School, is the founding partner of the Firm. After serving as a law clerk for United States District Judge Howard McKibben, he began his career as an associate at a New York law firm concentrating in securities litigation. Thereafter, he started a boutique law firm specializing in securities litigation, and other complex litigation EMERGENT BIOSOLUTIONS INC. Emergent BioSolutions Inc. On March 31, 2021, The New York Times published an article reporting that in late February 2021, employees at Emergent’s Baltimore manufacturing plant “mixed up” ingredients of the different COVID-19 vaccines, contaminating up to 15 million doses of the Johnson & Johnson (“J&J”) vaccine forcingregulators to
NEW YORK FIFTH AVENUE New York Securities Litigation Attorney Fifth Avenue 712 5th Avenue 31st Floor New York, NY 10019 Phone: 212-935-7400 toll-free: 877-935-7400 info@glancylaw.com New York Law Offices The attorneys at Glancy Prongay & Murray LLP have years of experience handling major litigation, including securities, antitrust, intellectual property, derivative, consumer products and employment casesFIBROGEN INC.
FibroGen, Inc. Stock Symbol. FGEN. On November 4, 2019, Plainview LLC (“Plainview”) published a report questioning the safety and efficacy of Fibrogen’s lead product candidate, Roxadustat. On this news, Fibrogen’s stock price fell $3.01 per share, or nearly 8%, to close at $37.01 per share on November 4, 2019, thereby injuringinvestors.
THOMAS J. KENNEDY
THOMAS J. KENNEDY works out of the New York office, where he specializes in securities, antitrust, and consumer litigation. He received a Juris Doctor degree from St. John’s University School of Law in 1995. At St. John’s, he was a member of the ST. JOHN’S JOURNAL OF LEGAL COMMENTARY. Mr. Kennedy graduated from Miami University in 1992 with a Bachelor of Science degree in Accounting and MISAPPROPRIATION OF CORPORATE FUNDS Moreover, when a company’s executives misappropriated corporate funds, management’s positive statements regarding the company’s or its management’s honesty or integrity may be false. Such statements may too give rise to a securities fraud claim. Another possible action to take against insiders that misappropriated funds is theGREGORY B. LINKH
GREGORY B. LINKH works out of the New York office, where he specializes in securities, shareholder derivative, antitrust, and consumer litigation. Greg graduated from the State University of New York at Binghamton in 1996 and from the University of Michigan Law School in 1999. While in law school, Greg externed with United States District Judge Gerald E. Rosen of the Eastern District of NATIONAL CLASS ACTION LAWYERS Glancy's class action lawyers litigate complex class action suits and individual claims against the world’s largest corporations in federal and state court. OUR TEAM | GLANCY PRONGAY & MURRAY LLPGLANCY PRONGAY MURRAY LLPGLANCYLAW
Attorney & Staff Search. Search By Name Search By letter. A B C D E F G H I J K L M N O P Q R S T U V W X Y Z CONTACT US | GLANCY PRONGAY & MURRAY LLPGLANCY PRONGAY MURRAYLLPGLANCY LAW
Our Locations. Glancy Prongay & Murray LLP Los Angeles. 1925 Century Park East Suite 2100 Los Angeles, CA 90067. 310-201-9150 Phone 310-432-1495 Fax. info@glancylaw.comLIONEL Z. GLANCY
LIONEL Z. GLANCY, a graduate of University of Michigan Law School, is the founding partner of the Firm. After serving as a law clerk for United States District Judge Howard McKibben, he began his career as an associate at a New York law firm concentrating in securities litigation. Thereafter, he started a boutique law firm specializing in securities litigation, and other complex litigation EMERGENT BIOSOLUTIONS INC. Emergent BioSolutions Inc. On March 31, 2021, The New York Times published an article reporting that in late February 2021, employees at Emergent’s Baltimore manufacturing plant “mixed up” ingredients of the different COVID-19 vaccines, contaminating up to 15 million doses of the Johnson & Johnson (“J&J”) vaccine forcingregulators to
NEW YORK FIFTH AVENUE New York Securities Litigation Attorney Fifth Avenue 712 5th Avenue 31st Floor New York, NY 10019 Phone: 212-935-7400 toll-free: 877-935-7400 info@glancylaw.com New York Law Offices The attorneys at Glancy Prongay & Murray LLP have years of experience handling major litigation, including securities, antitrust, intellectual property, derivative, consumer products and employment casesFIBROGEN INC.
FibroGen, Inc. Stock Symbol. FGEN. On November 4, 2019, Plainview LLC (“Plainview”) published a report questioning the safety and efficacy of Fibrogen’s lead product candidate, Roxadustat. On this news, Fibrogen’s stock price fell $3.01 per share, or nearly 8%, to close at $37.01 per share on November 4, 2019, thereby injuringinvestors.
THOMAS J. KENNEDY
THOMAS J. KENNEDY works out of the New York office, where he specializes in securities, antitrust, and consumer litigation. He received a Juris Doctor degree from St. John’s University School of Law in 1995. At St. John’s, he was a member of the ST. JOHN’S JOURNAL OF LEGAL COMMENTARY. Mr. Kennedy graduated from Miami University in 1992 with a Bachelor of Science degree in Accounting and MISAPPROPRIATION OF CORPORATE FUNDS Moreover, when a company’s executives misappropriated corporate funds, management’s positive statements regarding the company’s or its management’s honesty or integrity may be false. Such statements may too give rise to a securities fraud claim. Another possible action to take against insiders that misappropriated funds is theGREGORY B. LINKH
GREGORY B. LINKH works out of the New York office, where he specializes in securities, shareholder derivative, antitrust, and consumer litigation. Greg graduated from the State University of New York at Binghamton in 1996 and from the University of Michigan Law School in 1999. While in law school, Greg externed with United States District Judge Gerald E. Rosen of the Eastern District of CONTACT US | GLANCY PRONGAY & MURRAY LLP Our Locations. Glancy Prongay & Murray LLP Los Angeles. 1925 Century Park East Suite 2100 Los Angeles, CA 90067. 310-201-9150 Phone 310-432-1495 Fax. info@glancylaw.comREKOR SYSTEMS, INC.
Submit Your Information. If you suffered a loss on your Rekor Systems, Inc. investments or would like to inquire about joining an action to recover your loss under the federal secSKILLZ INC.
On this news, Skillz stock price fell $3.00 per share, or 10.9%, to close at $24.45, thereby injuring investors. On April 19, 2021, Eagle Eye Research posted an anonymous report on Twitter in which it claimed that, through the use of providing users with incentive Bonus Payments, “the company likely recognizes substantial non-cashrevenue and
IP LITIGATION LAWYERS IP Litigation Lawyers Protecting Intellectual Property Rights. Glancy Prongay & Murray LLP is committed to representing inventors, artists and businesses with intellectual property matters. Our IP litigation lawyers help you protect your intellectual property and are experienced in navigating highly technical patent practice. GPM’sattorneys
FIBROGEN INC.
FibroGen, Inc. Stock Symbol. FGEN. On November 4, 2019, Plainview LLC (“Plainview”) published a report questioning the safety and efficacy of Fibrogen’s lead product candidate, Roxadustat. On this news, Fibrogen’s stock price fell $3.01 per share, or nearly 8%, to close at $37.01 per share on November 4, 2019, thereby injuringinvestors.
APACHE CORPORATION
On this news, Apache's stock price fell $1.16, or 5%, to close at $22.07 per share on October 25, 2019, thereby injuring investors. Then, on February 26, 2020, post-market, the Company announced that it was completely de-valuing Alpine High after taking a $3 billion write-down on the project. Two weeks later, on March 12, 2020, Apacheannounced
LIFEMD, INC.
Specifically, according to Culper Research, “many customers are effectively duped into purchasing subscriptions rather than one-time purchases” and LifeMD “makes cancellations difficult if not impossible.”. On this news, the Company’s share price fell $2.84, or 24%, to close at $9.00 per share on April 14, 2021, on unusuallyheavy
9F INC. - GLANCY PRONGAY & MURRAY LLP In August 2019, 9F completed its initial public offering (“IPO”), selling approximately 8.9 million American Depositary Shares at $9.50 a share. On September 27, 2019, 9F repoCASEY E. SADLER
CASEY E. SADLER is a native of New York, New York. After graduating from the University of Southern California, Gould School of Law, Mr. Sadler joined the Firm in 2010. While attending law school, Mr. Sadler externed for the Enforcement Division of the Securities and Exchange Commission, spent a summer working for P.H. Parekh & Co. — one of the leading appellate law firms in New Delhi, IndiaIMMUNOMEDICS, INC.
Immunomedics, Inc. On December 17, 2018, FDAnews published an article reporting that “ he FDA cited Immunomedics for a host of violations – including its handling of a data integrity breach – observed at its Morris Plains, New Jersey, drug substance manufacturing facility between August 6 and 14.”. The article further reported that NATIONAL CLASS ACTION LAWYERS Glancy's class action lawyers litigate complex class action suits and individual claims against the world’s largest corporations in federal and state court. OUR TEAM | GLANCY PRONGAY & MURRAY LLPGLANCY PRONGAY MURRAY LLPGLANCYLAW
Attorney & Staff Search. Search By Name Search By letter. A B C D E F G H I J K L M N O P Q R S T U V W X Y Z CONTACT US | GLANCY PRONGAY & MURRAY LLPGLANCY PRONGAY MURRAYLLPGLANCY LAW
Our Locations. Glancy Prongay & Murray LLP Los Angeles. 1925 Century Park East Suite 2100 Los Angeles, CA 90067. 310-201-9150 Phone 310-432-1495 Fax. info@glancylaw.comLIONEL Z. GLANCY
LIONEL Z. GLANCY, a graduate of University of Michigan Law School, is the founding partner of the Firm. After serving as a law clerk for United States District Judge Howard McKibben, he began his career as an associate at a New York law firm concentrating in securities litigation. Thereafter, he started a boutique law firm specializing in securities litigation, and other complex litigation EMERGENT BIOSOLUTIONS INC. Emergent BioSolutions Inc. On March 31, 2021, The New York Times published an article reporting that in late February 2021, employees at Emergent’s Baltimore manufacturing plant “mixed up” ingredients of the different COVID-19 vaccines, contaminating up to 15 million doses of the Johnson & Johnson (“J&J”) vaccine forcingregulators to
NEW YORK FIFTH AVENUE New York Securities Litigation Attorney Fifth Avenue 712 5th Avenue 31st Floor New York, NY 10019 Phone: 212-935-7400 toll-free: 877-935-7400 info@glancylaw.com New York Law Offices The attorneys at Glancy Prongay & Murray LLP have years of experience handling major litigation, including securities, antitrust, intellectual property, derivative, consumer products and employment casesFIBROGEN INC.
FibroGen, Inc. Stock Symbol. FGEN. On November 4, 2019, Plainview LLC (“Plainview”) published a report questioning the safety and efficacy of Fibrogen’s lead product candidate, Roxadustat. On this news, Fibrogen’s stock price fell $3.01 per share, or nearly 8%, to close at $37.01 per share on November 4, 2019, thereby injuringinvestors.
THOMAS J. KENNEDY
THOMAS J. KENNEDY works out of the New York office, where he specializes in securities, antitrust, and consumer litigation. He received a Juris Doctor degree from St. John’s University School of Law in 1995. At St. John’s, he was a member of the ST. JOHN’S JOURNAL OF LEGAL COMMENTARY. Mr. Kennedy graduated from Miami University in 1992 with a Bachelor of Science degree in Accounting and MISAPPROPRIATION OF CORPORATE FUNDS Moreover, when a company’s executives misappropriated corporate funds, management’s positive statements regarding the company’s or its management’s honesty or integrity may be false. Such statements may too give rise to a securities fraud claim. Another possible action to take against insiders that misappropriated funds is theGREGORY B. LINKH
GREGORY B. LINKH works out of the New York office, where he specializes in securities, shareholder derivative, antitrust, and consumer litigation. Greg graduated from the State University of New York at Binghamton in 1996 and from the University of Michigan Law School in 1999. While in law school, Greg externed with United States District Judge Gerald E. Rosen of the Eastern District of NATIONAL CLASS ACTION LAWYERS Glancy's class action lawyers litigate complex class action suits and individual claims against the world’s largest corporations in federal and state court. OUR TEAM | GLANCY PRONGAY & MURRAY LLPGLANCY PRONGAY MURRAY LLPGLANCYLAW
Attorney & Staff Search. Search By Name Search By letter. A B C D E F G H I J K L M N O P Q R S T U V W X Y Z CONTACT US | GLANCY PRONGAY & MURRAY LLPGLANCY PRONGAY MURRAYLLPGLANCY LAW
Our Locations. Glancy Prongay & Murray LLP Los Angeles. 1925 Century Park East Suite 2100 Los Angeles, CA 90067. 310-201-9150 Phone 310-432-1495 Fax. info@glancylaw.comLIONEL Z. GLANCY
LIONEL Z. GLANCY, a graduate of University of Michigan Law School, is the founding partner of the Firm. After serving as a law clerk for United States District Judge Howard McKibben, he began his career as an associate at a New York law firm concentrating in securities litigation. Thereafter, he started a boutique law firm specializing in securities litigation, and other complex litigation EMERGENT BIOSOLUTIONS INC. Emergent BioSolutions Inc. On March 31, 2021, The New York Times published an article reporting that in late February 2021, employees at Emergent’s Baltimore manufacturing plant “mixed up” ingredients of the different COVID-19 vaccines, contaminating up to 15 million doses of the Johnson & Johnson (“J&J”) vaccine forcingregulators to
NEW YORK FIFTH AVENUE New York Securities Litigation Attorney Fifth Avenue 712 5th Avenue 31st Floor New York, NY 10019 Phone: 212-935-7400 toll-free: 877-935-7400 info@glancylaw.com New York Law Offices The attorneys at Glancy Prongay & Murray LLP have years of experience handling major litigation, including securities, antitrust, intellectual property, derivative, consumer products and employment casesFIBROGEN INC.
FibroGen, Inc. Stock Symbol. FGEN. On November 4, 2019, Plainview LLC (“Plainview”) published a report questioning the safety and efficacy of Fibrogen’s lead product candidate, Roxadustat. On this news, Fibrogen’s stock price fell $3.01 per share, or nearly 8%, to close at $37.01 per share on November 4, 2019, thereby injuringinvestors.
THOMAS J. KENNEDY
THOMAS J. KENNEDY works out of the New York office, where he specializes in securities, antitrust, and consumer litigation. He received a Juris Doctor degree from St. John’s University School of Law in 1995. At St. John’s, he was a member of the ST. JOHN’S JOURNAL OF LEGAL COMMENTARY. Mr. Kennedy graduated from Miami University in 1992 with a Bachelor of Science degree in Accounting and MISAPPROPRIATION OF CORPORATE FUNDS Moreover, when a company’s executives misappropriated corporate funds, management’s positive statements regarding the company’s or its management’s honesty or integrity may be false. Such statements may too give rise to a securities fraud claim. Another possible action to take against insiders that misappropriated funds is theGREGORY B. LINKH
GREGORY B. LINKH works out of the New York office, where he specializes in securities, shareholder derivative, antitrust, and consumer litigation. Greg graduated from the State University of New York at Binghamton in 1996 and from the University of Michigan Law School in 1999. While in law school, Greg externed with United States District Judge Gerald E. Rosen of the Eastern District of CONTACT US | GLANCY PRONGAY & MURRAY LLP Our Locations. Glancy Prongay & Murray LLP Los Angeles. 1925 Century Park East Suite 2100 Los Angeles, CA 90067. 310-201-9150 Phone 310-432-1495 Fax. info@glancylaw.comREKOR SYSTEMS, INC.
Submit Your Information. If you suffered a loss on your Rekor Systems, Inc. investments or would like to inquire about joining an action to recover your loss under the federal secSKILLZ INC.
On this news, Skillz stock price fell $3.00 per share, or 10.9%, to close at $24.45, thereby injuring investors. On April 19, 2021, Eagle Eye Research posted an anonymous report on Twitter in which it claimed that, through the use of providing users with incentive Bonus Payments, “the company likely recognizes substantial non-cashrevenue and
IP LITIGATION LAWYERS IP Litigation Lawyers Protecting Intellectual Property Rights. Glancy Prongay & Murray LLP is committed to representing inventors, artists and businesses with intellectual property matters. Our IP litigation lawyers help you protect your intellectual property and are experienced in navigating highly technical patent practice. GPM’sattorneys
FIBROGEN INC.
FibroGen, Inc. Stock Symbol. FGEN. On November 4, 2019, Plainview LLC (“Plainview”) published a report questioning the safety and efficacy of Fibrogen’s lead product candidate, Roxadustat. On this news, Fibrogen’s stock price fell $3.01 per share, or nearly 8%, to close at $37.01 per share on November 4, 2019, thereby injuringinvestors.
APACHE CORPORATION
On this news, Apache's stock price fell $1.16, or 5%, to close at $22.07 per share on October 25, 2019, thereby injuring investors. Then, on February 26, 2020, post-market, the Company announced that it was completely de-valuing Alpine High after taking a $3 billion write-down on the project. Two weeks later, on March 12, 2020, Apacheannounced
LIFEMD, INC.
Specifically, according to Culper Research, “many customers are effectively duped into purchasing subscriptions rather than one-time purchases” and LifeMD “makes cancellations difficult if not impossible.”. On this news, the Company’s share price fell $2.84, or 24%, to close at $9.00 per share on April 14, 2021, on unusuallyheavy
9F INC. - GLANCY PRONGAY & MURRAY LLP In August 2019, 9F completed its initial public offering (“IPO”), selling approximately 8.9 million American Depositary Shares at $9.50 a share. On September 27, 2019, 9F repoCASEY E. SADLER
CASEY E. SADLER is a native of New York, New York. After graduating from the University of Southern California, Gould School of Law, Mr. Sadler joined the Firm in 2010. While attending law school, Mr. Sadler externed for the Enforcement Division of the Securities and Exchange Commission, spent a summer working for P.H. Parekh & Co. — one of the leading appellate law firms in New Delhi, IndiaIMMUNOMEDICS, INC.
Immunomedics, Inc. On December 17, 2018, FDAnews published an article reporting that “ he FDA cited Immunomedics for a host of violations – including its handling of a data integrity breach – observed at its Morris Plains, New Jersey, drug substance manufacturing facility between August 6 and 14.”. The article further reported that NATIONAL CLASS ACTION LAWYERS Glancy's class action lawyers litigate complex class action suits and individual claims against the world’s largest corporations in federal and state court. OUR TEAM | GLANCY PRONGAY & MURRAY LLPGLANCY PRONGAY MURRAY LLPGLANCYLAW
Attorney & Staff Search. Search By Name Search By letter. A B C D E F G H I J K L M N O P Q R S T U V W X Y Z CONTACT US | GLANCY PRONGAY & MURRAY LLPGLANCY PRONGAY MURRAYLLPGLANCY LAW
Our Locations. Glancy Prongay & Murray LLP Los Angeles. 1925 Century Park East Suite 2100 Los Angeles, CA 90067. 310-201-9150 Phone 310-432-1495 Fax. info@glancylaw.comLIONEL Z. GLANCY
LIONEL Z. GLANCY, a graduate of University of Michigan Law School, is the founding partner of the Firm. After serving as a law clerk for United States District Judge Howard McKibben, he began his career as an associate at a New York law firm concentrating in securities litigation. Thereafter, he started a boutique law firm specializing in securities litigation, and other complex litigation EMERGENT BIOSOLUTIONS INC. On March 31, 2021, The New York Times published an article reporting that in late February 2021, employees at Emergent’s Baltimore manufacturing plant “mixed up” ingredientsFIBROGEN INC.
In 2019, FibroGen filed its New Drug Application (“NDA”) with the U.S. Food and Drug Administration (“FDA”) for the approval of roxadustat for the treatment of anemia due NEW YORK FIFTH AVENUE New York Securities Litigation Attorney Fifth Avenue 712 5th Avenue 31st Floor New York, NY 10019 Phone: 212-935-7400 toll-free: 877-935-7400 info@glancylaw.com New York Law Offices The attorneys at Glancy Prongay & Murray LLP have years of experience handling major litigation, including securities, antitrust, intellectual property, derivative, consumer products and employment casesTHOMAS J. KENNEDY
THOMAS J. KENNEDY works out of the New York office, where he specializes in securities, antitrust, and consumer litigation. He received a Juris Doctor degree from St. John’s University School of Law in 1995. At St. John’s, he was a member of the ST. JOHN’S JOURNAL OF LEGAL COMMENTARY. Mr. Kennedy graduated from Miami University in 1992 with a Bachelor of Science degree in Accounting andGREGORY B. LINKH
GREGORY B. LINKH works out of the New York office, where he specializes in securities, shareholder derivative, antitrust, and consumer litigation. Greg graduated from the State University of New York at Binghamton in 1996 and from the University of Michigan Law School in 1999. While in law school, Greg externed with United States District Judge Gerald E. Rosen of the Eastern District of MISAPPROPRIATION OF CORPORATE FUNDS Corporate officers and directors are not permitted to intentionally and illegally use corporate funds for personal gain or any other unauthorized purpose. NATIONAL CLASS ACTION LAWYERS Glancy's class action lawyers litigate complex class action suits and individual claims against the world’s largest corporations in federal and state court. OUR TEAM | GLANCY PRONGAY & MURRAY LLPGLANCY PRONGAY MURRAY LLPGLANCYLAW
Attorney & Staff Search. Search By Name Search By letter. A B C D E F G H I J K L M N O P Q R S T U V W X Y Z CONTACT US | GLANCY PRONGAY & MURRAY LLPGLANCY PRONGAY MURRAYLLPGLANCY LAW
Our Locations. Glancy Prongay & Murray LLP Los Angeles. 1925 Century Park East Suite 2100 Los Angeles, CA 90067. 310-201-9150 Phone 310-432-1495 Fax. info@glancylaw.comLIONEL Z. GLANCY
LIONEL Z. GLANCY, a graduate of University of Michigan Law School, is the founding partner of the Firm. After serving as a law clerk for United States District Judge Howard McKibben, he began his career as an associate at a New York law firm concentrating in securities litigation. Thereafter, he started a boutique law firm specializing in securities litigation, and other complex litigation EMERGENT BIOSOLUTIONS INC. On March 31, 2021, The New York Times published an article reporting that in late February 2021, employees at Emergent’s Baltimore manufacturing plant “mixed up” ingredientsFIBROGEN INC.
In 2019, FibroGen filed its New Drug Application (“NDA”) with the U.S. Food and Drug Administration (“FDA”) for the approval of roxadustat for the treatment of anemia due NEW YORK FIFTH AVENUE New York Securities Litigation Attorney Fifth Avenue 712 5th Avenue 31st Floor New York, NY 10019 Phone: 212-935-7400 toll-free: 877-935-7400 info@glancylaw.com New York Law Offices The attorneys at Glancy Prongay & Murray LLP have years of experience handling major litigation, including securities, antitrust, intellectual property, derivative, consumer products and employment casesTHOMAS J. KENNEDY
THOMAS J. KENNEDY works out of the New York office, where he specializes in securities, antitrust, and consumer litigation. He received a Juris Doctor degree from St. John’s University School of Law in 1995. At St. John’s, he was a member of the ST. JOHN’S JOURNAL OF LEGAL COMMENTARY. Mr. Kennedy graduated from Miami University in 1992 with a Bachelor of Science degree in Accounting andGREGORY B. LINKH
GREGORY B. LINKH works out of the New York office, where he specializes in securities, shareholder derivative, antitrust, and consumer litigation. Greg graduated from the State University of New York at Binghamton in 1996 and from the University of Michigan Law School in 1999. While in law school, Greg externed with United States District Judge Gerald E. Rosen of the Eastern District of MISAPPROPRIATION OF CORPORATE FUNDS Corporate officers and directors are not permitted to intentionally and illegally use corporate funds for personal gain or any other unauthorized purpose. CONTACT US | GLANCY PRONGAY & MURRAY LLP Our Locations. Glancy Prongay & Murray LLP Los Angeles. 1925 Century Park East Suite 2100 Los Angeles, CA 90067. 310-201-9150 Phone 310-432-1495 Fax. info@glancylaw.comSKILLZ INC.
On March 8, 2021, Wolfpack Research published a report about the Company alleging that the growth speculations from Skillz and its insiders were “entirely unrealistic” and thaREKOR SYSTEMS, INC.
Submit Your Information. If you suffered a loss on your Rekor Systems, Inc. investments or would like to inquire about joining an action to recover your loss under the federal secFIBROGEN INC.
In 2019, FibroGen filed its New Drug Application (“NDA”) with the U.S. Food and Drug Administration (“FDA”) for the approval of roxadustat for the treatment of anemia dueLIFEMD, INC.
On April 14, 2021, Culper Research issued a report alleging that “LifeMD appears to use unlicensed doctors to dispense OTC medications, has implemented an autoshipping/autobilli IP LITIGATION LAWYERS Our IP litigation lawyers assist inventors, artists and businesses. We protect intellectual property rights such as copyrights, trade secrets, licensing agreements and patents. 9F INC. - GLANCY PRONGAY & MURRAY LLP In August 2019, 9F completed its initial public offering (“IPO”), selling approximately 8.9 million American Depositary Shares at $9.50 a share. On September 27, 2019, 9F repoAPACHE CORPORATION
On April 23, 2019, pre-market, the Company announced that it had begun a "emporary" deferral of natural gas production at its Alpine High oil-and-gas resource play in the PermiIMMUNOMEDICS, INC.
On December 17, 2018, FDAnews published an article reporting that “he FDA cited Immunomedics for a host of violations – including its handling of a data integrity breach oCASEY E. SADLER
CASEY E. SADLER is a native of New York, New York. After graduating from the University of Southern California, Gould School of Law, Mr. Sadler joined the Firm in 2010. While attending law school, Mr. Sadler externed for the Enforcement Division of the Securities and Exchange Commission, spent a summer working for P.H. Parekh & Co. — one of the leading appellate law firms in New Delhi, IndiaSkip to Content __
__ Open Search Form
__ close search Site Search __ Search __ Join a Class Action __PORTFOLIO MONITORING LOGIN Secure Client Portal__ Menu
* Our Firm __ Next Tab* __ Back
* Class Action Attorneys * Portfolio Monitoring * Judicial Accolades* Community Service
* Careers
* Our Team
* Practice Areas
__ Next Tab
* __ Back
* Securities
* Antitrust
* Consumer Class Actions* IP Litigation
* Employment Class Actions * New Cases & Investigations* News & FAQs
* Contact __ Next Tab* __ Back
* Los Angeles
* Berkeley
* New York
* New York Fifth AvenueOur Experience
+ Dedication _Are YOUR Advantage_ Let Us Go To Work For YouPartnering with
Clients _25+ Years of Success_ Let Us Go To Work For YouUnparalleled Skill
& Service _UndeniableRESULTS_ Let Us Go To Work For YouAggressive
Approach _High ETHICAL Standards_ Let Us Go To Work For You* 1
* 2
* 3
* 4
Scroll
Search Site Go __
> Glancy Prongay & Murray is “qualified, experienced and able to > vigorously conduct the proposed litigation.”>
> _-Hon. Robert E. Blackburn, U.S. District Judge, Colorado_ GLANCY PRONGAY & MURRAY LLP: NATIONAL CLASS ACTION LAWYERS OUR EXPERIENCE AND DEDICATION ARE YOUR ADVANTAGE With more than 25 years of experience litigating and winning cases on behalf of individuals, institutional investors, businesses, consumers, and employees, Glancy Prongay & Murray LLP (“GPM”) is recognized as one of the leading plaintiff’s law firms in the nation. Our team of highly qualified class action lawyers and research analysts investigate and prosecute private actions for violations of securities, consumer, and antitrust law, as well as other forms of corporate wrongdoing. Representing clients from across the globe, GPM’s class action attorneys have successfully litigated complex class and individual actions against some of the world’s largest corporations in federal and state courts throughout the United States. Our attorneys are principled and fearless, and their ethical and aggressive approach to litigation has resulted in the recovery of billions of dollars for their clients.WHAT WE DO
SECURITIES LITIGATION GPM is committed to recovering investor losses resulting from securities fraud perpetrated by corporations or their officers and directors. We are a premier securities litigation firm, having served as court-appointed lead counsel in hundreds of complex class actions. Our securities fraud attorneys have been involved in some of the largest securities class action recoveries in history, collectively helping to recover billions of dollars for investors.Learn More
ANTITRUST LITIGATION The attorneys in our Antitrust Litigation Practice prosecute a wide range of cases involving an anticompetitive conduct, including price fixing, unlawful monopolization, and unfair trade practices. We are committed to protecting competition in the marketplace, and we vigorously represent individuals, businesses, and other entities that have been harmed by antitrust law violations.Learn More
CONSUMER PROTECTION LITIGATION Corporations that violate consumer protection laws should not be allowed to reap the benefits of their wrongdoing. GPM is an industry leader in litigating federal and state class actions covering the full spectrum of consumer issues, including defective products, privacy violations and data breaches, financial fraud, and other deceptive business practices. Our attorneys have recovered hundreds of millions of dollars for consumers who have been defrauded and taken advantage of by illegal corporate conduct.Learn More
INTELLECTUAL PROPERTY LITIGATION Our legal team has substantial experience litigating patent, copyright, and other intellectual property matters. We represent businesses and individuals who have been victimized by intellectual property infringement as well as parties who seek to combat abusive behaviors by intellectual property holders.Learn More
WHY CHOOSE GPM
WE FEARLESSLY ADVOCATE FOR OUR CLIENTS. Our law firm is fearless when it comes to protecting the rights of our clients. We relish a challenge and regularly take on large and powerful corporations. Our class action, securities fraud and consumer protection attorneys have achieved exceptional results for their clients against some of the most prominent and well-defended corporations in the world. PERSONALIZED SERVICE IS OUR HALLMARK. Our firm is devoted to providing attentive, high-quality representation. GPM lawyers are extremely responsive and give their full time and attention to each matter. We prioritize providing our clients with the information and advice they need at every turn throughout their case. A TRACK RECORD OF CLASS ACTION SUCCESS. We are experienced litigators capable of achieving exceptional outcomes for our clients. Our attorneys have collectively recovered billions of dollars for investors, consumers, and corporations throughout the course of their careers, and their efforts have been recognized by the _Wall Street Journal_, the _Los Angeles Times_, and other national news outlets and publications. OUR FIRM BEARS THE FINANCIAL RISK OF LITIGATION. At GPM we believe that the best legal representation involves establishing a true partnership with our clients. In this partnership, we carry the financial risk for our clients. We handle almost all our cases on a contingency fee basis, fronting all litigation expenses in exchange for a percentage of the amount recovered. If there is no recovery, clients do not pay for our time or the money we expended on their behalf. If there is a recovery, we are compensated and reimbursed out of the settlement fund or juryaward.
WE HANDLE COMPLEX, HIGH-STAKES CASES AND CLASS ACTIONS. Our attorneys litigate major cases, with almost all of our work involving class action lawsuits. We have the talent, experience, knowledge, and resources to handle the most complicated, high-stakes lawsuits, whether they are initiated as large-scale class actions orindividual cases.
WE REPRESENT CLIENTS ACROSS THE U.S. AND AROUND THE GLOBE. GPM attorneys represent individuals, institutional investors, consumers, corporations, and other victims of corporate fraud and wrongdoing across the United States and throughout the world. We are extremely proud of our long record of helping clients who have suffered serious financial losses, regardless of where they are based. WE OFFER A HIGHLY ACCOMPLISHED AND RESPECTED LEGAL TEAM. At GPM we are committed to excellence. We have been repeatedly ranked as one of the Top Plaintiff’s Law Firms in the United States by the Institutional Shareholder Services unit of RiskMetrics Group in its Securities Class Action Services report and our attorneys have received numerous awards and accolades for their work.COURT RECOGNITION
“And without question, the Court is of the opinion that the value of benefit that’s been conferred to the class is extremely sizable and that this Court is certainly aware that the skill and efficiency of plaintiff’s counsel is what attributed to this settlement, and they are learned securities counsel. The Court is mindful of that, and as a result they were able to sort of weed their way through the complex issues in this case, and also to bring this about — bring about a settlement rather in short order as these matters go. So the Court certainly attributes that to counsel’s skill and efficiency, as well as the ability to work with the adversaries in this matter.” _–Hon. Susan D. Wigention, U.S. District Judge, District of NewJersey_
“Class Counsel has conducted the litigation and achieved the Settlement in good faith and with skill, perseverance and diligentadvocacy”
_— Hon. Donovan W. Frank, U.S. District Judge, District ofMinnesota_
“The court finds that the Settlement Fund… created by Class Counsel is an exceptional result… The settlement is significantly above the average securities class action settlement when measured as a percentage of losses recovered… The court finds that Class Counsel, particularly Co-Lead Counsel, exerted tremendous effort on behalf of the class in the prosecution of this action… The Court finds that Class Counsel skillfully prosecuted this action, particularly given that this case was unusually complex relative to most securities fraud class actions. ” _–Hon. Dickran M. Tevrizian (Ret.), U.S. District Court Judge, Central District of California_* 1
* 2
* 3
More Testimonials
SECURITIES CASES & INVESTIGATIONSNEW CASES
* Virgin Galactic Holdings, Inc. * Provention Bio, Inc. * Array Technologies, Inc.* ContextLogic Inc.
* Skillz Inc.
INVESTIGATIONS
* Rekor Systems, Inc.* CarLotz, Inc.
* Adamis Pharmaceuticals Corporation * So-Young International Inc.* Porch Group Inc.
View All
OUR LOCATIONS
Glancy Prongay & Murray LLPLOS ANGELES
1925 Century Park EastSuite 2100
Los Angeles, CA 90067310-201-9150 Phone
310-432-1495 Fax
__ info@glancylaw.com Glancy Prongay & Murray LLPBERKELEY
1808 Sixth Street
Berkeley, CA 94710
415-972-8160 Phone
415-972-8166 Fax
__ info@glancylaw.com Glancy Prongay & Murray LLPNEW YORK
230 Park Ave
Suite 530
New York, NY 10169
212-682-5340 Phone
212-884-0988 Fax
__ jluckey@glancylaw.com Glancy Prongay & Murray LLPNEW YORK
FIFTH AVENUE
712 5th Avenue
31st floor
New York, NY 10019
212-935-7400 Phone
__ info@glancylaw.com__ __
__
Copyright © Glancy Prongay & Murray LLP 2003 - 2021. All Rights Reserved. Sitemap | Disclaimer | Privacy Policy | This Website Contains AttorneyAdvertising
Details
Copyright © 2024 ArchiveBay.com. All rights reserved. Terms of Use | Privacy Policy | DMCA | 2021 | Feedback | Advertising | RSS 2.0